MCID: RTT002
MIFTS: 77

Rett Syndrome malady

Categories: Genetic diseases, Rare diseases, Mental diseases, Neuronal diseases

Aliases & Classifications for Rett Syndrome

About this section
Sources:
50OMIM, 11Disease Ontology, 69Wikipedia, 46NIH Rare Diseases, 23GeneTests, 24Genetics Home Reference, 47NINDS, 13DISEASES, 52Orphanet, 68UniProtKB/Swiss-Prot, 25GTR, 12diseasecard, 48Novoseek, 36MedlinePlus, 37MeSH, 66UMLS, 28ICD10, 43NCIt, 29ICD10 via Orphanet, 38MESH via Orphanet, 67UMLS via Orphanet, 35MedGen, 60SNOMED-CT, 62The Human Phenotype Ontology
See all MalaCards sources

Aliases & Descriptions for Rett Syndrome:

Name: Rett Syndrome 50 11 69 46 23 24 47 13 52 68 12 48 36 37 66
Atypical Rett Syndrome 46 52 25
Rett Syndrome Zappella Variant 68 25
Rett Syndrome, Atypical 50 66
Rett Syndrome Variant 46 52
Rett's Disorder 11 24
Rett's Syndrome 24 25
Rett Disorder 24 68
Rtt 24 68
 
Rts 24 68
Autism-Dementia-Ataxia-Loss of Purposeful Hand Use Syndrome 24
Autism, Dementia, Ataxia, and Loss of Purposeful Hand Use 46
Autism-Dementia-Ataxia-Loss of Purposeful Hand Use 68
Rett Syndrome, Preserved Speech Variant 50
Rett Syndrome Preserved Speech Variant 68
Cerebroatrophic Hyperammonemia 11
Rett Like Syndrome 46
Atypical Rtt 52

Characteristics:

Orphanet epidemiological data:

52
rett syndrome:
Inheritance: X-linked dominant; Prevalence: 1-5/10000 (Europe); Age of onset: Infancy,Neonatal; Age of death: adult
atypical rett syndrome:
Inheritance: Autosomal dominant,X-linked dominant; Age of onset: Infancy,Neonatal; Age of death: any age

HPO:

62
rett syndrome:
Inheritance: x-linked dominant inheritance


Classifications:



External Ids:

OMIM50 312750
Disease Ontology11 DOID:1206
ICD1028 F84.2
MeSH37 D015518
NCIt43 C75488
SNOMED-CT60 192583003, 68618008
ICD10 via Orphanet29 F84.2
MESH via Orphanet38 D015518
UMLS via Orphanet67 C0035372

Summaries for Rett Syndrome

About this section
NIH Rare Diseases:46 Atypical rett syndrome is a neurodevelopmental disorder that is diagnosed when a child has some of the symptoms of rett syndrome but does not meet all the diagnostic criteria. like the classic form of rett syndrome, atypical rett syndrome mostly affects girls. children with atypical rett syndrome can have symptoms that are either milder or more severe than those seen in rett syndrome. several subtypes of atypical rett syndrome have been defined:the early-onset seizure type is characterized by seizures in the first months of life with later development of rett features (including developmental problems, loss of language skills, and repeated hand wringing or hand washing movements). it is frequently caused by mutations in the x-linked cdkl5 gene (xp22). the congenital variant is the most severe form of atypical rett syndrome, with onset of classic rett features during the first three months of life. this variant is generally caused by mutations in the foxg1 gene (14q11-q13). the forme fruste is a milder variant with onset in early childhood and an incomplete and prolonged course. the late childhood regression form is characterized by a normal head circumference and by a more gradual and later onset (late childhood) regression of language and motor skills. the preserved speech variant is marked by recovery of some verbal and manual skills and is caused in at least some cases by mutations in the mecp2 (xq28) gene, which is also responsible for the majority of cases of classic rett syndrome. diagnosis relies on clinical evaluation using the diagnostic criteria for atypical rett syndrome which was defined by hagberg in 1994. molecular genetic testing may confirm the diagnosis. last updated: 2/12/2013

MalaCards based summary: Rett Syndrome, also known as atypical rett syndrome, is related to encephalopathy, neonatal severe and rett syndrome, congenital variant, and has symptoms including stereotypy, gait disturbance and abnormality of the voice. An important gene associated with Rett Syndrome is MECP2 (Methyl-CpG Binding Protein 2), and among its related pathways are Biogenic Amine Synthesis and Sympathetic Nerve Pathway (Pre- and Post- Ganglionic Junction). Affiliated tissues include brain, bone and testes, and related mouse phenotypes are taste/olfaction and craniofacial.

Disease Ontology:11 A pervasive developmental disease that is characterized by normal early growth and development followed by a slowing of development, loss of purposeful use of the hands, distinctive hand movements, slowed brain and head growth, problems with walking, seizures, and intellectual disability.

UniProtKB/Swiss-Prot:68 Rett syndrome: An X-linked dominant neurodevelopmental disorder, and one of the most common causes of mental retardation in females. Patients appear to develop normally until 6 to 18 months of age, then gradually lose speech and purposeful hand movements, and develop microcephaly, seizures, autism, ataxia, mental retardation and stereotypic hand movements. After initial regression, the condition stabilizes and patients usually survive into adulthood.

MedlinePlus:36 Rett syndrome is a rare genetic disease that causes developmental and nervous system problems, mostly in girls. it's related to autism spectrum disorder. babies with rett syndrome seem to grow and develop normally at first. between 3 months and 3 years of age, though, they stop developing and even lose some skills. symptoms include loss of speech loss of hand movements such as grasping compulsive movements such as hand wringing balance problems breathing problems behavior problems learning problems or intellectual disability rett syndrome has no cure. you can treat some of the symptoms with medicines, surgery, and physical and speech therapy. most people with rett syndrome live into middle age and beyond. they will usually need care throughout their lives. nih: national institute of child health and human development

NINDS:47

Genetics Home Reference:24 Rett syndrome is a brain disorder that occurs almost exclusively in girls. The most common form of the condition is known as classic Rett syndrome. After birth, girls with classic Rett syndrome have 6 to 18 months of apparently normal development before developing severe problems with language and communication, learning, coordination, and other brain functions. Early in childhood, affected girls lose purposeful use of their hands and begin making repeated hand wringing, washing, or clapping motions. They tend to grow more slowly than other children and have a small head size (microcephaly). Other signs and symptoms that can develop include breathing abnormalities, seizures, an abnormal side-to-side curvature of the spine (scoliosis), and sleep disturbances.

OMIM:50 Rett syndrome is a neurodevelopmental disorder that occurs almost exclusively in females. It is characterized by... (312750) more...

Wikipedia:69 Rett syndrome (RTT), originally termed cerebroatrophic hyperammonemia, is a rare genetic postnatal... more...

Related Diseases for Rett Syndrome

About this section

Diseases in the Rett Syndrome family:

Rett Syndrome, Congenital Variant

Diseases related to Rett Syndrome via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50)    (show all 120)
idRelated DiseaseScoreTop Affiliating Genes
1encephalopathy, neonatal severe25.9BDNF, CDKL5, CHAT, DLX5, DLX6, FOXG1
2rett syndrome, congenital variant12.2
3classic rett syndrome12.1
4epileptic encephalopathy, early infantile, 211.6
5rothmund-thomson syndrome11.6
6atypical teratoid rhabdoid tumor11.5
7rubinstein-taybi syndrome11.4
8ring chromosome 310.7MBD4, MECP2
9clcn2-related juvenile myoclonic epilepsy10.6FOXG1, MBD4, MECP2, UBE3A
10roifman-chitayat syndrome10.6CDKL5, MBD4, MECP2, UBE3A
11west syndrome10.6BDNF, CHAT, TH
12peyronie's disease10.6CDKL5, FOXG1, MECP2, TH
13atypical autism10.5BDNF, CDKL5, FOXG1, MECP2, UBE3A
14gingival disease10.5CHAT, TH
15neuronitis10.5
16pervasive developmental disorder10.4
17angiomyolipoma10.4BDNF, CHAT, TH
18breast cancer10.4
19leukemia10.4
20intravascular angioleiomyoma10.3CDKL5, MECP2
21epilepsy10.3
22microphthalmia, syndromic 110.3MECP2, MRXSL
23ck syndrome10.3MECP2, MRXSL
24chronic intestinal vascular insufficiency10.3BDNF, CHAT, TH
25mental retardation, x-linked syndromic, lubs type10.3MECP2, MRXSL
26candida glabrata10.2
27scoliosis10.2
28rhabdoid cancer10.2
29prostatitis10.2
30autism susceptibility, x-linked 310.2MECP2, MRXSL
31cdkl5-related disorder10.2
32melanoma10.1
33colorectal cancer10.1
34prostate cancer10.1
35myeloid leukemia10.1
36sarcoma10.1
37thyroiditis10.1
38autism spectrum disorder10.1
39gastric cancer10.1
40hepatitis10.1
41peritonitis10.0
42encephalopathy10.0
43lymphoma10.0
44adenocarcinoma10.0
45lung cancer10.0
46intellectual disability10.0
47hypoxia10.0
48influenza10.0
49endotheliitis10.0
50neuroblastoma9.9

Graphical network of the top 20 diseases related to Rett Syndrome:



Diseases related to rett syndrome

Symptoms for Rett Syndrome

About this section

Symptoms by clinical synopsis from OMIM:

312750

Clinical features from OMIM:

312750

Symptoms:

 52 (show all 54)
  • abnormality of the teeth
  • microcephaly
  • macrotia
  • behavioral abnormality
  • depression
  • autism
  • stereotypic behavior
  • abnormality of the skull
  • acrocyanosis
  • abnormality of the metacarpal bones
  • seizures
  • ataxia
  • spasticity
  • muscle weakness
  • dystonia
  • joint stiffness
  • failure to thrive
  • narrow foot
  • respiratory insufficiency
  • cerebral cortical atrophy
  • apraxia
  • hepatomegaly
  • arnold-chiari malformation
  • eeg abnormality
  • dysphasia
  • developmental regression
  • tetraplegia
  • scoliosis
  • arthrogryposis multiplex congenita
  • decreased muscle mass
  • clinodactyly of the 5th finger
  • short stature
  • hemiplegia/hemiparesis
  • abnormality of the antihelix
  • intellectual disability, severe
  • arrhythmia
  • thin fingernail
  • abnormality of movement
  • self-injurious behavior
  • wide mouth
  • long philtrum
  • hearing impairment
  • underdeveloped nasal alae
  • wide nose
  • nephrolithiasis
  • abnormality of the fingernails
  • intellectual disability
  • gastroesophageal reflux
  • ventriculomegaly
  • fine hair
  • aplasia/hypoplasia of the cerebellum
  • abnormality of the antitragus
  • thick vermilion border
  • camptodactyly of finger

HPO human phenotypes related to Rett Syndrome:

(show all 66)
id Description Frequency HPO Source Accession
1 stereotypy hallmark (90%) HP:0000733
2 gait disturbance hallmark (90%) HP:0001288
3 abnormality of the voice hallmark (90%) HP:0001608
4 neurological speech impairment hallmark (90%) HP:0002167
5 developmental regression hallmark (90%) HP:0002376
6 cognitive impairment hallmark (90%) HP:0100543
7 abnormality of the eye typical (50%) HP:0000478
8 seizures typical (50%) HP:0001250
9 hypertonia typical (50%) HP:0001276
10 muscle weakness typical (50%) HP:0001324
11 tremor typical (50%) HP:0001337
12 respiratory insufficiency typical (50%) HP:0002093
13 cerebral cortical atrophy typical (50%) HP:0002120
14 incoordination typical (50%) HP:0002311
15 sleep disturbance typical (50%) HP:0002360
16 scoliosis typical (50%) HP:0002650
17 kyphosis typical (50%) HP:0002808
18 acrocyanosis typical (50%) HP:0001063
19 muscular hypotonia typical (50%) HP:0001252
20 gait disturbance typical (50%) HP:0001288
21 neurological speech impairment typical (50%) HP:0002167
22 fine hair typical (50%) HP:0002213
23 eeg abnormality typical (50%) HP:0002353
24 abnormal pattern of respiration typical (50%) HP:0002793
25 microcephaly occasional (7.5%) HP:0000252
26 autism occasional (7.5%) HP:0000717
27 limitation of joint mobility occasional (7.5%) HP:0001376
28 apnea occasional (7.5%) HP:0002104
29 hepatomegaly occasional (7.5%) HP:0002240
30 abnormality of the autonomic nervous system occasional (7.5%) HP:0002270
31 skeletal muscle atrophy occasional (7.5%) HP:0003202
32 reduced bone mineral density occasional (7.5%) HP:0004349
33 hemiplegia/hemiparesis occasional (7.5%) HP:0004374
34 arrhythmia occasional (7.5%) HP:0011675
35 self-injurious behavior occasional (7.5%) HP:0100716
36 brachydactyly syndrome occasional (7.5%) HP:0001156
37 hypertonia occasional (7.5%) HP:0001276
38 obesity occasional (7.5%) HP:0001513
39 weight loss occasional (7.5%) HP:0001824
40 short toe occasional (7.5%) HP:0001831
41 abnormality of the teeth HP:0000164
42 autistic behavior HP:0000729
43 seizures HP:0001250
44 spasticity HP:0001257
45 dystonia HP:0001332
46 short foot HP:0001773
47 constipation HP:0002019
48 gastroesophageal reflux HP:0002020
49 gait ataxia HP:0002066
50 truncal ataxia HP:0002078
51 cerebral cortical atrophy HP:0002120
52 intellectual disability, profound HP:0002187
53 motor deterioration HP:0002333
54 eeg abnormality HP:0002353
55 developmental regression HP:0002376
56 scoliosis HP:0002650
57 kyphosis HP:0002808
58 skeletal muscle atrophy HP:0003202
59 bruxism HP:0003763
60 short stature HP:0004322
61 cachexia HP:0004326
62 intermittent hyperventilation HP:0004879
63 ekg HP:0005135
64 prolonged qtc interval HP:0005184
65 postnatal microcephaly HP:0005484
66 gait apraxia HP:0010521

UMLS symptoms related to Rett Syndrome:


back pain, cachexia, constipation, headache, muscle spasticity, pain, sciatica, seizures, sleep disturbances, syncope, tremor, chronic pain, ataxia, truncal, vertigo/dizziness, gait ataxia, sleeplessness

Drugs & Therapeutics for Rett Syndrome

About this section

Drugs for Rett Syndrome (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show all 41)
idNameStatusPhaseClinical TrialsCas NumberPubChem Id
1
GuaifenesinPhase 3, Phase 260393-14-13516
Synonyms:
3-(2-Methoxyphenoxy)-1,2-propanediol
3-(O-Methoxyphenoxy)-1,2-propanediol
3-(O-Methoxyphenoxy)-propanediol-1,2
3-O-Methoxyphenoxypropane 1:2-diol
Actifed C
Aeronesin
Amonidren
Amonidrin
Aresol
Benylin-E
Bronchol
Glycerin ether
Glycerin guaiacolate
Glycero-guaiacol ether
Glycerol a-(2-methoxyphenyl) ether
Glycerol a-(O-methoxyphenyl)ether
Glycerol a-guaiacyl ether
Glycerol a-guiacyl ether
Glycerol a-monoguaiacol ether
Glycerol guaiacolate
Glycerol mono(2-methoxyphenyl) ether
Glycerol-a-guajakolether
Glycerol-alpha-guajakolether
Glyceryl guaiacol
Glyceryl guaiacol ether
Glyceryl guaiacolate
Glyceryl guaiacolate ether
Glyceryl guaiacyl ether
Glyceryl guaicolate
Glyceryl guiacolate
 
Glycerylguaiacol
Guaiacol glycerol ether
Guaiacol glyceryl ether
Guaiacolglicerinetere
Guaiacuran
Guaiacurane
Guaiacyl glyceryl ether
Guaiamar
Guaianesin
Guaicol glycerine ether
Guaicol glyceryl ether
Guaifenesin
Guaifenesine
Guaiphenesin
Guaiphenesine
Guaiphesin
Hustosil
Methoxypropanediol
Methphenoxydiol
Metossipropandiolo
O-Methoxyphenyl glyceryl ether
Organidin NR
Pneumomist
Propanosedyl
Reduton
Robitussin
a-Glyceryl guaiacol ether
a-Glyceryl guaiacolate ether
alpha-Glyceryl guaiacol ether
alpha-Glyceryl guaiacolate ether
guaiphenesin
p-Cresyl acetate
2
PhenylpropanolaminePhase 3, Phase 260314838-15-426934
Synonyms:
(+)-Norephedrine
(+-)-Norephedrin
(+-)-Norephedrine
(+/-)-Norephedrin
(-)-Norephedrin
(-)-Norephedrine
(.+-.)-Norephedrine
(1R,2S)-Norephedrine
.psi.-Norephedrine
134-60-1
14838-15-4
16960-27-3
1926-74-5
2-amino-1-phenylpropan-1-ol
27818-48-0
282553_ALDRICH
317500_ALDRICH
36393-56-3
36393-57-4
37577-07-4
37577-28-9
48115-38-4
492-39-7
492-41-1
6891-23-2
700-65-2
74530_FLUKA
AB00375975
AB1001936
AC1L1C6K
AC1L1IYB
AC1L1UWH
AC1L4QZI
AC1Q59PM
AR-1J0987
AR-1J0988
Acutrim
Ami-Tex
BIDD:GT0376
BPBio1_000361
BRN 2802895
BRN 3196918
BSPBio_000327
BSPBio_003292
C02343
C07911
C16719
C9H13NO
CHEBI:327494
CHEMBL136560
CID10297
CID162265
CID26934
CID4786
Cathina
Cathine
Cathine [INN]
Cathinum
Cathinum [INN-Latin]
Codimal
Conex
Contuss
D-(+)-Norephedrine
D08368
DB00397
DEA No. 1230
DL-Norephedrine
DL-Phenylpropanolamine
Despec
Dexatrim
DivK1c_000795
DivK1c_007030
Dura-Vent
EINECS 207-754-1
EINECS 207-755-7
EINECS 211-850-9
EINECS 238-900-2
EINECS 253-014-6
Exponcit
Fansia
Fansia (TN)
Fenilpropanolamina
Fugoa
Fugoa Depot
Gentab
Guaipax
HMS2090P12
HSDB 6485
Hydriatine
I01-8913
I01-8924
IDI1_000795
KBio1_000795
KBio1_001974
KBio2_001583
KBio2_004151
 
KBio2_006719
KBio3_001778
KBio3_002512
KBioGR_001385
KBioGR_001950
KBioSS_001583
Katine
L-(-)-Norephedrine
L-NOREPHEDRINE
L-Phenyl Propanolamine
L001077
LS-176795
LS-97284
LS-97285
LS-97461
LS-97462
Minusine
MolPort-001-769-340
MolPort-001-788-006
MolPort-001-794-194
MolPort-001-794-233
Mucorama
Mucron
Mydriatin
Myminic
NCGC00178157-01
NCGC00178157-02
NINDS_000795
NSC 17704
NSC 9920
NSC120735
NSC17704
NSC9920
Nobese
Nolex
Norephedrin
Norephedrine
Norpseudoephedrine
Obestat
PDSP1_001348
PDSP1_001349
PDSP1_001354
PDSP2_001332
PDSP2_001333
PDSP2_001338
PPA
Partuss
Phenoxine
Phenyldrine
Phenylfenesin
Phenylpropanolamin
Phenylpropanolamina
Phenylpropanolamine
Phenylpropanolaminum
Phénylpropanolamine
Prestwick0_000324
Prestwick1_000324
Prestwick2_000324
Prestwick3_000324
Prestwick_388
Propadrine
Propagest
Pseudonorephedrine
Rhindecon
Rhymed
SPBio_000051
SPBio_000471
SPBio_002248
SPECTRUM2300253
Snaplets
SpecPlus_000934
Spectrum2_000016
Spectrum2_000516
Spectrum3_000889
Spectrum3_001706
Spectrum4_000983
Spectrum4_001685
Spectrum5_000330
Spectrum5_001156
Spectrum_001103
Super Odrinex
TAVIST-D
ULR
UNII-33RU150WUN
UNII-E1L4ZW2F8O
USAF CS-6
Vanex
WLN: ZY1&YQR
WLN: ZY1&YQR -L
d-Nor-psi-ephedrine
d-Norpseudoephedrine
dl-Norephedrine
l-Nor-psi-ephedrin
l-Nor-psi-ephedrine
l-Norephedrine
phenylpropanolamine
psi-Norephedrine
β-hydroxyamphetamine
3
DopaminePhase 3367851-61-6, 62-31-7681
Synonyms:
(3H)-Dopamine
.Beta.-(3,4-Dihydroxyphenyl)ethylamine hydrochloride
.alpha.-(3,4-Dihydroxyphenyl)-.beta.-aminoethane
1,2-Benzenediol, 4-(2-aminoethyl)- (9CI)
1,2-Benzenediol, 4-(2-aminoethyl)-, hydrochloride
1,2-Benzenediol, 4-(2-aminoethyl)-, labeled with tritium
153C5321-5FEE-4B0B-8925-F388F0EEEBD1
2-(3,4-Dihydroxyphenyl)ethylamine
2-(3,4-dihydroxyphenyl)ethylamine
2-benzenediol
3,4-Dihydroxyphenethylamine
3,4-Dihydroxyphenethylamine hydrochloride
3,4-Dihydroxyphenylethylamine
3,4-dihydroxyphenethylamine
3-Hydroxtyramine
3-Hydroxytyramine
3-Hydroxytyramine Hydrobromide
3-Hydroxytyramine hydrochloride
4-(2-Aminoethyl)-1,
4-(2-Aminoethyl)-1,2-benzenediol
4-(2-Aminoethyl)-1,2-bezenediol
4-(2-Aminoethyl)-Pyrocatechol
4-(2-Aminoethyl)benzene-1,2-diol
4-(2-Aminoethyl)catechol
4-(2-Aminoethyl)pyrocatechol
4-(2-Aminoethyl)pyrocatechol hydrochloride
4-(2-aminoethyl)-pyrocatechol
50444-17-2
51-61-6
62-31-7 (HYDROCHLORIDE)
AC1L19S5
AC1Q54AX
AC1Q54AY
AKOS003790978
ASL 279
BIDD:ER0506
BPBio1_001123
BSPBio_001932
Biomol-NT_000001
C03758
CHEBI:18243
CHEMBL59
CID681
D07870
DB00988
Deoxyepinephrine
DivK1c_000780
Dopamin
Dopamina
Dopamina [INN-Spanish]
Dopamine
Dopamine (INN)
Dopamine (USAN)(*hydrochloride*)
Dopamine [INN:BAN]
Dopaminum
Dopaminum [INN-Latin]
Dopastat
Dophamine
Dynatra
EINECS 200-110-0
HSDB 3068
Hydroxytyramin
Hydroxytyramine
IDI1_000780
IP 498
Intropin
Intropin [*hydrochloride*]
KBio1_000780
 
KBio2_001492
KBio2_002388
KBio2_002484
KBio2_004060
KBio2_004956
KBio2_005052
KBio2_006628
KBio2_007524
KBio2_007620
KBio3_001152
KBio3_002867
KBio3_002962
KBioGR_001129
KBioGR_002388
KBioGR_002484
KBioSS_001492
KBioSS_002393
KBioSS_002491
KW-3-060
L-DOPAMINE
L000232
LDP
LS-159
Lopac-H-8502
Lopac0_000586
Medopa (TN)
MolPort-001-641-000
NCGC00015519-01
NCGC00015519-08
NCGC00096050-01
NCGC00096050-02
NCGC00096050-03
NCGC00096050-04
NCGC00096050-05
NINDS_000780
NSC 173182
NSC169105
NSC173182
Oprea1_088821
Oxytyramine
Pyrocatechol, 4-(2-aminoethyl)- (8CI)
Pyrocatechol, 4-(2-aminoethyl)-, hydrochloride
Revimine
Revivan
SPBio_001205
SPECTRUM1505155
ST048774
STK301601
Spectrum2_001023
Spectrum3_000406
Spectrum4_000525
Spectrum5_000945
Spectrum_001012
UNII-VTD58H1Z2X
UPCMLD0ENAT5885989:001
a-(3,4-Dihydroxyphenyl)-b-aminoethane
alpha-(3,4-Dihydroxyphenyl)-beta-aminoethane
cMAP_000036
cMAP_000065
dopamine
hydroxytyramine
intropin
m-Hydroxytyramine hydrochloride
nchembio.105-comp9
nchembio.107-comp4
nchembio.284-comp1
nchembio.78-comp16
nchembio.89-comp3
nchembio705-8
nchembio801-comp8
4
DonepezilPhase 3275120014-06-43152
Synonyms:
( inverted exclamation markA)-E 2020
1-Benzyl-4-[(5,6-dimethoxy-1-oxoindan-2-yl)methyl]piperidine
120014-06-4
2-[(1-benzylpiperidin-4-yl)methyl]-5,6-dimethoxy-2,3-dihydroinden-1-one
2-[(1-benzylpiperidin-4-yl)methyl]-5,6-dimethoxyindan-1-one
AB1004836
AC-6969
AC1L1FAE
AKOS000277311
Aricept
Aricept ODT
C24H29NO3
CHEBI:53289
CHEMBL502
CID3152
D07869
DB00843
Domepezil
Donaz
Donaz (TN)
 
Donepezil
Donepezil (INN)
Donepezil [INN:BAN]
Donepezil hydrochloride
Donepezilo
Donepezilum
Eranz
I06-0343
KBio2_002144
KBio2_004712
KBio2_007280
KBioSS_002144
LS-81819
MolPort-000-881-588
MolPort-003-847-014
NCGC00167537-01
Oprea1_188452
Spectrum5_001662
Spectrum_001664
TL8000531
UNII-8SSC91326P
5
DextromethorphanPhase 3, Phase 2127125-71-35360696, 5362449
Synonyms:
( )-3-Methoxy-N-methylmorphinon
( )-cis-1,3,4,9,10,10a-Hexahydro-6-methoxy-11-methyl-2H-10,4alpha-iminoethanophenanthren
(+)-3-Methoxy-17-methylmorphinan
(+)-dextromethorphan
(-)-3-Methoxy-N-methylmorphinan
(9alpha,13alpha,14alpha)-17-methyl-3-(methyloxy)morphinan
125-69-9 (hydrobromide)
125-70-2
125-71-3
18046-32-7
18609-21-7 (hydrochloride)
3-Methoxy-17-methyl-9alpha,13alpha,14alpha-morphinan
3-Methoxy-17-methylmorphinan
32062-10-5
4-21-00-01367 (Beilstein Handbook Reference)
6700-34-1 (hydrobromide, mono-hydrate)
9alpha,13alpha,14alpha-Morphinan, 3-methoxy-17-methyl- (8CI)
AC-13098
AC1L1EYT
Albutussin
Antussan
BA 2666
BPBio1_000503
BRD-K33211335-337-03-7
BRN 0088549
BSPBio_000457
Balminil DM
Balminil DM Children
Bayer Select Flu Relief
Bayer Select Head & Chest Cold
Bayer Select Night Time Cold
Benylin Adult Formula Cough Suppressant
Benylin DM
Benylin DM (TN)
Benylin DM 12 Hour
Benylin DM for Children
Benylin DM for Children 12 Hour
Benylin Pediatric Cough Suppressant
C06947
CHEBI:128891
CHEBI:4470
CHEBI:580686
CHEMBL22207
CHEMBL52440
CID3008
CID5360696
CID5362449
Calmylin #1
Canfodion
Cerose-DM
Chloraseptic DM
Contac Day & Night Cold/Flu Day Caplets
Contac Jr. Non-drowsy Formula
Contac Nighttime Cold Medicine
Contac Severe Cold Formula Maximum Strength
Contac Severe Cold Formula Non-Drowsy
Coricidin Syrup
Cosylan
Cough-X
Creo-Terpin
D-Methorphan
D-Methorphan Hydrobromide
D-methorphan
D03742
DB00514
DEA No. 9210
DM
DXM
Delsym
Delsym Cough Formula
Delta-Methorphan
Demorphan
Demorphan Hydrobromide
Demorphan hydrobromide
Demorphine
Destrometerfano
Destrometerfano [DCIT]
Destrometerfano [Dcit]
Dex
Dextromethorfan
Dextromethorfan [Czech]
Dextromethorphan
Dextromethorphan (USP)
Dextromethorphan Bromhydrate
Dextromethorphan Bromide
Dextromethorphan [USP:INN:BAN]
Dextromethorphan hydrobromide OROS Tablets
Dextromethorphan hydrobromide [BAN:JAN]
Dextromethorphan hydrobromide monohydrate
Dextromethorphane
Dextromethorphane [INN-French]
Dextromethorphanum
Dextromethorphanum [INN-Latin]
Dextrometorfano
Dextrometorfano [INN-Spanish]
Dextrometorphan
Dextromorphan
Dextrométhorphane
Dexyromethorphan
Diabe-Tuss DM Syrup
 
Dimacol
Dimetapp DM
Dormetan
Dormethan
Drixoral Cough
Drixoral Cough & Congestion
Drixoral Cough & Sore Throat
EINECS 204-751-7
EINECS 204-752-2
Endotussin-NN
Endotussin-NN Pediatric
HMS2090C08
HSDB 3056
Hihustan M.
Hold
Hold DM
Koffex DM
L-Methorphan
LS-91837
LS-91838
Levomethorphan
Levomethorphan [BAN:DCF:INN]
Levomethorphan [Ban:Dcf:Inn]
Levomethorphan [INN:BAN:DCF]
Levomethorphane
Levomethorphane [INN-French]
Levomethorphanum
Levomethorphanum [INN-Latin]
Levometorfano
Levometorfano [INN-Spanish]
Lopac-D-2531
Lopac0_000337
MLS000758303
Medicon
Methorate
Methorate Hydrobromide
Methorphan
Metrorat
MolPort-003-940-943
MolPort-004-285-957
Morphinan, 3-methoxy-17-methyl-, (9-alpha,13-alpha,14-alpha)- (9CI)
NCGC00015333-01
NCGC00015333-02
NCGC00015333-04
NCGC00162126-01
Naldecon-DX
Novahistex DM
Novahistine DM
Ornex Severe Cold Formula
Orthoxicol
PediaCare 1
PediaCare Cough-Cold Formula
Pertussin CS Children's Strength
Pertussin DM Extra Strength
Prestwick0_000359
Prestwick1_000359
Prestwick2_000359
Prestwick3_000359
Prestwick_686
RACEMETHORPHAN
Robitussin CF
Robitussin Cold & Cough
Robitussin Cough Calmers
Robitussin DM
Robitussin Maximum Strength Cough
Robitussin Maximum Strength Cough Suppressant
Robitussin Pediatric
Robitussin Pediatric Cough
Robitussin Pediatric Cough & Cold
Robitussin Pediatric Cough Suppressant
Robitussin Pediatric Night Relief
Romilar
Rondec dm
Ru-Tuss Expectorant
SPBio_002378
St. Joseph Cough Syrup
Sucrets 4 Hour Cough Suppressant
Sudafed Cough Syrup
Triaminic
Triaminic DM Long Lasting for Children
Trind-DM
Trocal
Tusilan
Tussade
Tussar DM
Tussi-Organidin
Tussi-Organidin DM NR
Tussi-Organidin DM-S NR
Tylenol Cold No Drowsiness
Tylenol Cold and Flu Multi-Symptom
Tylenol Cold and Flu No Drowsiness
Tylenol Cough + Decongestant Liquid
Tylenol Cough Liquid
Tylenol Flu No Drowsiness Gelcaps
UNII-7355X3ROTS
Vicks 44 Cough Relief
Viro-Med
d-Methorphan
delta-Methorphan
dextromethorphan
l-Methorphan
6
RisperidonePhase 3482106266-06-25073
Synonyms:
106266-06-2
3-(2-(4-(6-Fluoro-1,2-benzisoxazol-3-yl)piperidino)ethyl)-6,7,8,9-tetrahydro-2-methyl-4H-pyrido(1,2-a)pyrimidin-4-one
3-(2-[4-(6-fluoro-benzo[d]isoxazol-3-yl)-piperidin-1-yl]-ethyl)-2-methyl-6,7,8,9-tetrahydro-pyrido[
3-(2-[4-(6-fluoro-benzo[d]isoxazol-3-yl)-piperidin-1-yl]-ethyl)-2-methyl-6,7,8,9-tetrahydropyrido[1,
3-[2-[-4-(6-fluoro-1,2-benzisoxazol-3-yl)-1-piperidinyl]ethyl]-6,7,8,9-tetrahydro-2-methyl-4H-pyrido[1,2-a]pyrimidin-4-one
3-[2-[4-(6-Fluoro-1,2-benzisoxazol-3-yl)-1-piperidinyl]-6,7,8,9-tetrahydro-2-methyl-4H-pyrido [1,2-a] pyrimidin-4-one
3-[2-[4-(6-Fluoro-1,2-benzisoxazol-3-yl)piperi-dino]ethyl]-6,7,8,9-tetrahydro-2-methyl-4H-pyrido[1,2-a]-pyrimidin-4-one
3-[2-[4-(6-fluoro-1,2-benzisoxazol-3-yl)-1-piperidinyl]ethyl]-6,7,8,9-tetrahydro-2-methyl-4H-pyrido[1,2-a]pyrimidin-4-one
3-[2-[4-(6-fluoro-1,2-benzoxazol-3-yl)piperidin-1-yl]ethyl]-2-methyl-6,7,8,9-tetrahydropyrido[1,2-a]pyrimidin-4-one
3-[2-[4-(6-fluoro-benzo[d]isoxazol-3-yl)-piperidin-1-yl]-ethyl]-2-methyl-6,7,8,9-tetrahydropyrido[1,
3-{2-[4-(6-Fluoro-benzo[d]isoxazol-3-yl)-piperidin-1-yl]-ethyl}-2-methyl-6,7,8,9-tetrahydropyrido[1,2-a]pyrimidin-4-one
3-{2-[4-(6-fluoro-1,2-benzisoxazol-3-yl)piperidin-1-yl]ethyl}-2-methyl-6,7,8,9-tetrahydro-4H-pyrido[1,2-a]pyrimidin-4-one
3-{2-[4-(6-fluoro-1,2-benzoxazol-3-yl)piperidin-1-yl]ethyl}-2-methyl-6,7,8,9-tetrahydro-4H-pyrido[1,2-a]pyrimidin-4-one
AB00514010
AC-1306
AC1L1JJU
BIDD:GT0262
BRD-K53857191-001-04-5
BRN 4891881
Belivon
Bio-0092
Buspirone
C23H27FN4O2
CAS-106266-06-2
CHEBI:8871
CHEMBL85
CID5073
CPD000466323
Consta, Risperdal
D00426
D018967
DB00734
EU-0101074
HMS1571M19
HMS2051H07
HMS2089C22
HSDB 7580
I01-1156
Jsp000573
KS-1106
L000510
LS-134196
Lopac-R-118
MLS000759429
MLS001165758
MLS001424081
MolPort-002-885-858
 
NCGC00015883-01
NCGC00015883-02
NCGC00015883-03
NCGC00094352-01
NCGC00094352-02
NCGC00094352-03
NCGC00179257-01
Prestwick0_001029
Prestwick1_001029
R 62 766
R 64 766, Risperdal, Risperidone
R 64,766
R 64766
R-118
R-64,766
R-64-766
R-64766
R64,766
R64766
Rispen
Risperdal
Risperdal (TN)
Risperdal Consta
Risperdal M-Tab
Risperidal
Risperidal M-Tab
Risperidona
Risperidona [Spanish]
Risperidone
Risperidone (JAN/USAN/INN)
Risperidone (RIS)
Risperidone [USAN:BAN:INN]
Risperidone, placebo
Risperidonum
Risperidonum [Latin]
Risperin
Rispolept
Rispolin
S1615_Selleck
SAM001246595
SMR000466323
SPBio_003078
STK646402
Sequinan
Spiron
TL8000230
UNII-L6UH7ZF8HC
risperdone
risperidone
7
SerotoninPhase 3351050-67-95202
Synonyms:
3-(2-Aminoethyl)-1H-indol-5-ol
3-(2-Aminoethyl)indol-5-ol
3-(b-Aminoethyl)-5-hydroxyindole
5-HT
5-HTA
5-Hydroxy-3-(b-aminoethyl)indole
 
5-Hydroxy-tryptamine
5-Hydroxyltryptamine
5-Hydroxytriptamine
5-Hydroxytryptamine
Antemovis
DS substance
Enteramin
Enteramine
8
DesipraminePhase 23950-47-52995
Synonyms:
(3-(10H,11H-Dibenzo[b,f]azepin-5-yl)propyl)methylamine
10, 11-Dihydro-N-methyl-5H-dibez[b,f]azepine-5-propanamine
10,11-Dihydro-5-(3-methylaminopropyl)-5H-dibenz(b,f)azepine
3-(10,11-DIHYDRO-5H-DIBENZO[B,F]AZEPIN-5-YL)-N-METHYLPROPAN-1-AMINE
3-(10,11-DIHYDRO-5H-dibenzo[b,F]azepin-5-yl)-N-methylpropan-1-amine
3-(5,6-dihydrobenzo[b][1]benzazepin-11-yl)-N-methylpropan-1-amine
5-(gamma-Methylaminopropyl)iminodibenzyl
5-(γ-methylaminopropyl)iminodibenzyl
50-47-5
58-28-6 (hydrochloride)
AB00053450
AC-15977
AC1L1EXQ
AKOS001681456
BPBio1_000447
BRN 1432747
BSPBio_000405
BSPBio_002137
C06943
CAS-58-28-6
CCRIS 7091
CHEBI:47781
CHEMBL72
CID2995
D07791
DB01151
DB07682
DMI
DMI (pharmaceutical)
DMI 50475
Demethylimipramine
Desimipramine
Desimpramine
Desipramin
Desipramina
Desipramina [INN-Spanish]
Desipramine
Desipramine (D4)
Desipramine (INN)
Desipramine Hcl
Desipramine [INN:BAN]
Desipraminum
Desipraminum [INN-Latin]
Desmethylimipramine
Dezipramine
Dimethylimipramine
DivK1c_000190
Déméthylimipramine
 
EINECS 200-040-0
HSDB 3052
IDI1_000190
KBio1_000190
KBio2_000921
KBio2_003489
KBio2_006057
KBio3_001357
KBioGR_000928
KBioSS_000921
L001089
LS-60421
Lopac-D-3900
Lopac0_000358
Methylaminopropyliminodibenzyl
MolPort-002-051-955
Monodemethylimipramine
N-(3-Methylaminopropyl)iminobibenzyl
N-(3-methylaminopropyl)iminobibenzyl
NCGC00015340-01
NCGC00015340-02
NCGC00015340-03
NCGC00015340-10
NCGC00024375-04
NINDS_000190
Norimipramine
Norpramin
Norpramine
Pentofran
Pertofran
Pertrofane
Prestwick0_000343
Prestwick1_000343
Prestwick2_000343
Prestwick3_000343
SPBio_000042
SPBio_002326
STK735144
STOCK2S-34822
Sertofran
Spectrum2_000091
Spectrum3_000379
Spectrum4_000314
Spectrum5_000833
Spectrum_000441
UNII-TG537D343B
ZERO/006017
desipramine
desipraminum
9
LovastatinPhase 26075330-75-553232
Synonyms:
(1S,3R,7S,8S,8AR)-1,2,3,7,8,8a-hexahydro-3,7-dimethyl-8-(2-(2R,4R)-(tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl)ethyl)-1-naphthalenyl (S)-2-methyl-butyrate
1cqp
2beta,6alpha-Dimethyl-8alpha-(2-methyl-1-oxobutoxy)-mevinic acid lactone
6 Methylcompactin
6 alpha-Methylcompactin
6-Methylcompactin
6-alpha-Methylcompactin
6-alpha-methylcompactin
6alpha-Methylcompactin
6α-methylcompactin
71949-96-7
74133-25-8
75330-75-5
81739-26-6
AC-13961
AC1L1EI6
AC1Q2C7T
ACon0_000534
ACon1_000390
ARONIS24208
Altocor
Altoprev
Artein
BB_NC-1457
BIDD:GT0749
BIDD:PXR0113
BPBio1_000519
BRD-K09416995-001-06-8
BRN 3631989
BSPBio_000471
BSPBio_001265
BSPBio_003346
Belvas
C07074
C24H36O5
CCRIS 8092
CHEBI:40303
CHEMBL503
CID53232
CPD-5561
CPD000673570
Cholestra
Closterol
Colevix
D00359
D008148
DB00227
DivK1c_001032
HMS1569H13
HMS1792O07
HMS1923O13
HMS1990O07
HMS2089M06
HMS2093O03
HMS503O05
HSDB 6534
Hipolip
Hipovastin
I06-1876
IDI1_001032
KBio1_001032
KBio3_002848
L-154803
L0214
LOVASTATIN
LS-46359
Lestatin
Lipdip
Lipivas
Lipofren
 
Liposcler
Lovalip
Lovalord
Lovastatin & Primycin
Lovastatin (USP/INN)
Lovastatin [USAN:BAN:INN]
Lovastatin, (1 alpha(S*))-Isomer
Lovastatin, 1 alpha-Isomer (without R*/S* notation)
Lovastatina
Lovastatina [Spanish]
Lovastatine
Lovastatine [French]
Lovastatinum
Lovastatinum [Latin]
Lovasterol
Lovastin
Lozutin
M2147_SIGMA
MEGxm0_000398
MK 803
MK-803
MK803
ML-530B
ML-530b
MLS000069585
MLS001055358
MSD 803
Mevacor
Mevacor (TN)
Mevinacor
Mevinolin
Mevinolin from Aspergillus sp.
Mevlor
MolPort-001-739-990
Monacolin K
Monacolin-K
Monakolin K
NCGC00023509-03
NCGC00023509-04
NCGC00023509-05
NCGC00023509-06
NCGC00023509-07
NCGC00023509-08
NINDS_001032
Nergadan
Paschol
Prestwick0_000516
Prestwick1_000516
Prestwick2_000516
Prestwick3_000516
Prestwick_819
Rextat
Rodatin
Rovacor
SAM002589963
SMR000058779
SMR000673570
SPBio_002392
SPECTRUM1503977
STK801953
Sivlor
Spectrum3_001873
Spectrum5_001294
Taucor
Tecnolip
Teroltrat
UNII-9LHU78OQFD
ZINC03812841
lovastatin
nchembio742-comp5
nchembio790-comp14
nchembio869-comp12
10UbiquinonePhase 2132
11
MethylprednisolonePhase 2111883-43-26741
Synonyms:
(6S,8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-17-(2-hydroxyacetyl)-6,10,13-trimethyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-one
(6a,11b)-11,17,21-Trihydroxy-6-methylpregna-1,4-diene-3,20-dione
(6alpha,11beta)-11,17,21-Trihydroxy-6-methylpregna-1,4-diene-3,20-dione
(6α,11β)-11,17,21-trihydroxy-6-methylpregna-1,4-diene-3,20-dione
.DELTA.1-6.alpha.-Methylhydrocortisone
1-Dehydro-6alpha-methylhydrocortisone
1-dehydro-6alpha-Methylhydrocortisone
1-dehydro-6α-methylhydrocortisone
11-beta,17,21-Trihydroxy-6-alpha-methylpregna-1,4-diene-3,20-dione
11beta,17,21-Trihydroxy-6alpha-methylpregna-1,4-diene-3,20-dione
11beta,17alpha,21-Trihydroxy-6alpha-methyl-1,4-pregnadiene-3,20-dione
11beta,17alpha,21-Trihydroxy-6alpha-methylpregna-1,4-diene-3,20-dione
121673-01-6
4-08-00-03498 (Beilstein Handbook Reference)
46436_FLUKA
46436_RIEDEL
570-35-4
6 Methylprednisolone
6-Methylprednisolone
6-alpha-Methylprednisolone
6.alpha.-Methylprednisolone
6923-42-8
6alpha-Methyl-11beta,17alpha,21-trihydroxy-1,4-pregnadiene-3,20-dione
6alpha-Methyl-11beta,17alpha,21-triol-1,4-pregnadiene-3,20-dione
6alpha-Methylprednisolone
6alpha-methyl-11beta,17alpha,21-triol-1,4-pregnadiene-3,20-dione
83-43-2
AC1L1N7A
Artisone-Wyeth
Artisone-wyeth
BPBio1_000174
BRD-K35240538-001-03-1
BRN 2340300
BSPBio_000158
Besonia
Bio-0658
CHEBI:6888
CHEMBL650
CID6741
CPD000058330
D00407
D008775
DB00959
Depo-Medrol (acetate)
Dopomedrol
EINECS 201-476-4
Esametone
Firmacort
HMS1568H20
HMS2090B13
HSDB 3127
LMST02030178
LS-118498
Lemod
M0639_SIGMA
M1665
MEPRDL
MLS000028541
MLS001148159
MLS002207191
Medesone
Medixon
Medlone 21
 
Medrate
Medrol
Medrol (TN)
Medrol Adt Pak
Medrol Dosepak
Medrol adt pak
Medrol dosepak
Medrol, Solu-Medrol, Medrone, Methylprednisolone
Medrone
Mesopren
Metastab
Methyleneprednisolone
Methylprednisolon
Methylprednisolone
Methylprednisolone (JP15/USP/INN)
Methylprednisolone [USAN:INN:BAN:JAN]
Methylprednisolone, 6-alpha
Methylprednisolonum
Methylprednisolonum [INN-Latin]
Metilbetasone
Metilprednisolona
Metilprednisolona [INN-Spanish]
Metilprednisolone
Metilprednisolone [DCIT]
Metilprednisolone [Dcit]
Metipred
Metrisone
Metrocort
Metysolon
Moderin
MolPort-002-528-554
NCGC00022735-03
NCI60_001657
NSC-19987
NSC19987
Nirypan
Noretona
Predni N Tablinen
Prednol- L
Pregna-1,4-diene-3,20-dione, 11beta,17,21-trihydroxy-6alpha-methyl- (8CI)
Prestwick0_000279
Prestwick1_000279
Prestwick2_000279
Prestwick3_000279
Prestwick_622
Promacortine
Reactenol
S1733_Selleck
SAM002589984
SMR000058330
SPBio_002377
Sieropresol
Solomet
Summicort
Suprametil
U 7532
UNII-X4W7ZR7023
Urbason
Urbasone
Wyacort
ZINC03875560
delta(1)-6alpha-Methylhydrocortisone
delta(sup 1)-6-alpha-Methylhydrocortisone
methylprednisolone
methylprenisolone
12
MesnaPhase 225519767-45-4, 3375-50-6598
Synonyms:
2-Mercaptoethanesulfonate
2-Mercaptoethanesulfonic acid
 
2-mercaptoethane sulfonate Na
CoM
Coenzyme M
HS-CoM
13lenograstimPhase 21178
14glucocorticoidsPhase 24756
15
MiconazolePhase 2357322916-47-84189
Synonyms:
(+-)-1-(2,4-Dichloro-beta-((2,4-dichlorobenzyl)oxy)phenethyl)imidazole
1-(2,4-Dichloro-beta-((2,4-dichlorobenzyl)oxy)phenethyl)imidazole
1-(2,4-dichloro-beta-((2,4-dichlorobenzyl)oxy)phenethyl) imidazole
1-[2,4-Dichloro- beta-([2,4-dichloro- benzyl]oxy)phenethyl]imidazole
1-[2-(2,4-Dichloro-benzyloxy)-2-(2,4-dichloro-phenyl)-ethyl]-1H-imidazole
1-[2-(2,4-Dichlorophenyl)-2-[(2,4-dichlorophenyl)methoxy]ethyl]-1H-imidazole
1-[2-(2,4-dichlorobenzyloxy)-2-(2,4-dichlorophenyl)ethyl]-1H-imidazole
1-[2-(2,4-dichlorophenyl)-2-[(2,4-dichlorophenyl)methoxy]ethyl]imidazole
1-[2-(2,4-dichlorophenyl)-2-{[(2,4-dichlorophenyl)methyl]oxy}ethyl]-1H-imidazole
1-{2-[(2,4-dichlorobenzyl)oxy]-2-(2,4-dichlorophenyl)ethyl}-1H-imidazole
22832-87-7 (NITRATE)
22916-47-8
75319-47-0
AB00053500
AC1L1HM1
AKOS001574474
Aflorix(nitrate)
Albistat(nitrate)
Andergin(nitrate)
BPBio1_000279
BRD-A82396632-001-03-0
BRD-A82396632-008-02-7
BRN 0965511
BSPBio_000253
BSPBio_002033
CCRIS 7924
CHEBI:6923
CHEMBL91
CID4189
CPD-4501
Conofite(nitrate)
D00416
DB01110
Dactarin
Daktarin IV
Daktarin iv
DivK1c_000156
EINECS 245-324-5
Epi-Monistat(nitrate)
Femizol-M
Florid(nitrate)
Gyno-Daktar(nitrate)
HMS1568M15
HMS2090B21
I14-14342
IDI1_000156
Imidazole, 1-(2-(2,4-dichlorophenyl)-2-((2,4-dichlorophenyl)methoxy)ethyl)- (9CI)
KBio1_000156
KBio2_001445
KBio2_004013
KBio2_006581
KBio3_001533
KBioGR_000581
KBioSS_001445
LS-78378
Lotrimin AF(nitrate)
MCZ
MJR 1762
MLS002222203
Micantin (nitrate)
Miconasil Nitrate
 
Miconazol
Miconazol [INN-Spanish]
Miconazole
Miconazole (JP15/USP/INN)
Miconazole 3
Miconazole 3 Combination Pack
Miconazole 7 Combination Pack
Miconazole [USAN:BAN:INN:JAN]
Miconazole nitrate salt
Miconazole-7
Miconazolo
Miconazolo [DCIT]
Miconazolum
Miconazolum [INN-Latin]
Micozole
Minostate
MolPort-002-557-553
Monazole 7
Monista (nitrate)
Monistat
Monistat (TN)
Monistat 1 Combination Pack
Monistat 3 Dual-Pak
Monistat 3 Vaginal Ovules
Monistat 5 Tampon
Monistat 7 Dual-Pak
Monistat 7 Vaginal Suppositories
Monistat Dual- PAK
Monistat IV
Monistat iv (TN)
Monistat iv (tn)
Monistat-Derm
NCI60_001353
NCI60_001380
NINDS_000156
NSC 170986
NSC169434
NSC170986
Novo-Miconazole Vaginal Ovules
Oprea1_091955
Prestwick0_000067
Prestwick1_000067
Prestwick2_000067
Prestwick3_000067
Prestwick_335
R 18134
R-14,889
SMR001307249
SPBio_000976
SPBio_002174
STK834405
STOCK1S-93556
Spectrum2_001048
Spectrum3_000507
Spectrum4_000061
Spectrum5_001297
Spectrum_000965
UNII-7NNO0D7S5M
Vusion
Zimycan
imidazole, 1-(2-(2,4-dichlorophenyl)-2-((2,4-dichlorophenyl) methoxy)ethyl)- (9CI)
miconazole
16
Mycophenolate mofetilPhase 2919128794-94-55281078
Synonyms:
115007-34-6
128794-94-5
140401-05-4
2-Morpholinoethyl (4E)-6-(4-hydroxy-6-methoxy-7-methyl-3-oxo-5-phthalanyl)-4-methyl-4-hexenoate
2-Morpholinoethyl (E)-6-(4-hydroxy-6-methoxy-7-methyl-3-oxo-5-phthalanyl)-4-methyl-4-hexenoate
2-Morpholinoethyl (e)-6-(4-hydroxy-6-methoxy-7-methyl-3-oxo-5-phthalanyl)-4-methyl-4-hexenoate
2-morpholin-4-ylethyl (4E)-6-[4-hydroxy-7-methyl-6-(methyloxy)-3-oxo-1,3-dihydro-2-benzofuran-5-yl]-4-methylhex-4-enoate
2-morpholin-4-ylethyl (E)-6-(4-hydroxy-6-methoxy-7-methyl-3-oxo-1H-2-benzofuran-5-yl)-4-methylhex-4-enoate
4-Hexenoic acid, 6-(1,3-dihydro-4-hydroxy-6-methoxy-7-methyl -3-oxo-5-isobenzofuranyl)-4-methyl-, 2-(4-morpholinyl)ethyl ester, (4E)
AC-1562
AC1NQXZW
AC1Q6O6X
AR-1J6939
BB_NC-2566
C07908
C23H31NO7
CHEMBL1456
CID5281078
CellCept
CellCept, RS 61443, TM-MMF, Mycophenolate mofetil
Cellcept
Cellcept (TN)
D00752
DB00688
HMS2090A03
 
HSDB 7436
I01-0898
I06-1947
LS-172272
LS-75572
ME-MPA
MMF
MMF CellCept(TM)
MolPort-000-883-800
Munoloc
Mycophenolate mofetil (JAN/USAN)
Mycophenolic acid morpholinoethyl ester
Mycophenylate mofetil
NCGC00159459-02
NCGC00159459-03
NSC724229
R-99
RS 61443
RS-61443
RS-61443-190
S1501_Selleck
TL8000648
TM-MMF
UNII-9242ECW6R0
ZINC21297660
mycophenolate mofetil
17
VidarabinePhase 247524356-66-932326, 21704
Synonyms:
(+)-Cyclaradine
.beta.-Adenosine
.beta.-D-Adenosine
1odi
2-(6-AMINO-purin-9-yl)-5-hydroxymethyl-tetrahydro-furan-3,4-diol
2946-52-3
2fqy
2gl0
30143-02-3
3080-29-3
3228-71-5
4005-33-8
46946-45-6
46969-16-8
524-69-6
5536-17-4
58-61-7
9-Arabinosyladenine
9-beta-D-Arabinofuranosyl-9H-purin-6-amine
9-beta-D-Arabinofuranosyl-adenine
9-beta-D-Arabinofuranosyladenine
9-beta-D-arabinofuranosyl-adenine
9-β-D-arabinofuranosyl-9H-purin-6-amine
9-β-D-arabinofuranosyladenine
A 9251
A0152
A4036_SIGMA
A4676_SIGMA
A5762_SIGMA
A9251_SIGMA
AC1L18OL
AC1L1U8O
AC1L2IWM
AC1L2SCM
AC1O4WIN
AC1O8PY7
AC1Q1ID3
AC1Q4Y1Z
AC1Q52XU
ADENOSINE, U.S.P.
ADN
AI3-52413
AI3-52821
AR-1H6029
ARA-A NSC 247519
Ade-Rib
Adenine Arabinoside
Adenine arabinoside
Adenine nucleoside
Adenine riboside
Adenine xyloside
Adenocard
Adenocard (TN)
Adenocard, Adenosine
Adenocor
Adenoscan
Adenoscan (TN)
Adenosin
Adenosin [German]
Adenosine (JAN/USP)
Adenosine [USAN:BAN]
Adenosine arabinose
Adenosine-8-14C
Adensoine
Ambap5536-17-4
Ara A
Ara-A
Ara-ATP
Araadenosine
Arabinoside Adenine
Arabinoside adenine
Arabinosyl Adenine
Arabinosyl adenine
Arabinosyl-adenine
Arabinosyladenine
Arasena-A
Armes
Armes (TN)
BB_NC-0565
BPBio1_000898
BRN 0624881
BSPBio_000816
BSPBio_001796
BSPBio_002000
Bio1_000437
Bio1_000926
Bio1_001415
Boniton
C00212
CAS-5536-17-4
CCRIS 2557
CCRIS 3383
CHEBI:136932
CHEBI:16335
CHEBI:45327
CHEMBL1090
CHEMBL20247
CHEMBL477
CI 673
CI-673
CID102198
CID191
CID21704
CID60961
CID6420052
CID6713976
CPD000471872
Caswell No. 010B
D000241
D00045
D06298
DB00640
DivK1c_000191
EINECS 200-389-9
EINECS 217-911-6
EINECS 226-893-9
EU-0100123
FT-0082881
HMS1570I18
HMS1920A13
HMS1921K05
HMS2090F06
HMS2091G13
HMS2092C16
HMS500J13
HSDB 6514
 
I01-1121
IDI1_000191
KBio1_000191
KBio2_002418
KBio2_004986
KBio2_007554
KBio3_001296
KBio3_001500
KBioGR_001224
KBioSS_002424
L000094
LS-15059
LS-15085
Lopac0_000123
MEDR-640
MLS000069638
MLS000699527
MLS001066352
MLS001333133
MLS001333134
MLS002153227
MLS002153992
MolPort-001-785-903
MolPort-001-838-229
MolPort-003-666-308
Myocol
NCGC00016656-01
NCGC00023673-03
NCGC00023673-04
NCGC00023673-05
NCGC00023673-06
NCGC00023673-07
NCGC00094579-01
NCGC00094579-02
NCGC00094579-03
NCGC00094579-04
NCGC00178869-01
NCGC00179417-01
NCI60_003823
NCI60_037192
NCIOpen2_003303
NCIOpen2_005376
NINDS_000191
NSC 247519
NSC 404241
NSC 627048
NSC 7359
NSC 7652
NSC-404241
NSC247519
NSC404241
NSC627048
NSC70422
NSC7359
NSC7652
NSC80832
NSC87676
NSC91041
Nucleocardyl
PDSP1_001036
PDSP2_001020
Pallacor
Polyadenosine
Polyriboadenosine
Prestwick0_000768
Prestwick1_000768
Prestwick2_000768
Prestwick3_000768
Prestwick_983
RAB
S1647_Selleck
S1784_Selleck
SAM002564191
SMP1_000312
SMR000058216
SMR000225041
SMR000471872
SMR001233326
SPBio_001194
SPBio_001491
SPBio_002755
SPECTRUM1500107
SPECTRUM1500609
SR 96225
SR-96225
STK361815
SUN-Y4001
Sandesin
Spectrum2_001257
Spectrum2_001336
Spectrum3_000288
Spectrum3_000580
Spectrum4_000782
Spectrum5_001429
Spectrum_001894
Spongoadenosine
TL8003749
UNII-3XQD2MEW34
UNII-K72T3FS567
USAF CB-10
V0098
VIRDARABINE
Vidarabin
Vidarabina
Vidarabina [DCIT]
Vidarabine
Vidarabine (JAN)
Vidarabine anhydrous
Vidarabinum
Vira ATM
Vira-A
Vira-A, Vidarabine
XA
Xylosyl A
Xylosyladenine
ZINC00970363
ZINC02169830
adenine-D-ribose
adenosine
alpha-Ara A
beta-Adenosine
beta-Ara A
beta-D-Adenosine
bmse000061
nchembio.143-comp9
nchembio.186-comp109
nchembio.64-comp4
nchembio706-5
18PREDNISOLONE ACETATEPhase 21118
19
PrednisolonePhase 2111850-24-85755
Synonyms:
(11beta)-11,17,21-Trihydroxypregna-1,4-diene-3,20-dione
.DELTA.1-Cortisol
.DELTA.1-Dehydrocortisol
.DELTA.1-Dehydrohydrocortisone
.DELTA.1-Hydrocortisone
.delta.-Cortef
.delta.-Stab
1,2-Dehydrohydrocortisone
1,4-Pregnadiene-11beta,17alpha,21-triol-3,20-dione
1,4-Pregnadiene-3,20-dione-11beta,17alpha,21-triol
1-Dehydrocortisol
1-Dehydrohydrocortisone
3,20-dioxo-11beta,17alpha,21-Trihydroxy-1,4-pregnadiene
46656_FLUKA
46656_RIEDEL
50-24-8
58201-11-9
8056-11-9
AC-1773
AC1L1L2E
Ak-Pred
Ak-Tate
Alphadrol
Articulose-50
BPBio1_000164
BRD-K98039984-001-03-0
BRN 1354103
BSPBio_000148
Bio-0666
Bubbli-Pred
C07369
CCRIS 980
CHEBI:8378
CHEMBL131
CID5755
CO-Hydeltra
CPD000718761
Co-Hydeltra
Codelcortone
Cordrol
Cortalone
Cotogesic
Cotolone
D00472
D011239
DB00860
Decaprednil
Decortin H
Delcortol
Delta F
Delta(1)-dehydrohydrocortisone
Delta-Cortef
Delta-Cortef (TN)
Delta-Ef-Cortelan
Delta-Stab
Delta-stab
Deltacortenol
Deltacortril
Deltacortril Enteric
Deltahydrocortisone
Deltasolone
Deltisilone
Depo-Medrol
Derpo PD
Derpo Pd
Dexa-Cortidelt Hostacortin H
Dexa-Cortidelt hostacortin H
Di Adreson F
Di-Adreson F
Di-Adreson-F
Di-adreson F
DiAdresonF
Dicortol
Donisolone
Dydeltrone
EINECS 200-021-7
Eazolin D
Econopred
Econopred Plus
Erbacort
Erbasona
Estilsona
Fernisolone
Fernisolone P
Fernisolone-P
Flamasone
HMS1568H10
HMS2090J05
HSDB 3385
Hostacortin H
Hydeltra
Hydeltra-Tba
Hydeltrasol
Hydeltrone
Hydrodeltalone
Hydrodeltisone
Hydroretrocortin
Hydroretrocortine
I-Pred
Inflamase Forte
Inflamase Mild
K 1557
Key-Pred
Klismacort
LMST02030179
LS-7669
Lentosone
Lite Pred
M-Predrol
 
MLS001304083
MLS002154250
MLS002207037
Medrol
Medrol Acetate
Metacortandralone
Methylprednisolone Acetate
Meti-Derm
Meticortelone
Metreton
MolPort-002-507-147
NCGC00179649-01
NSC 9120
NSC9120
NSC9900
Neo-Delta-Cortef
Nisolone
Nor-Pred T.B.A.
Ocu-Pred
Ocu-Pred Forte
Ophtho-Tate
Orapred
P0152_SIGMA
P0637
P6004_SIGMA
PRDL
PRED-G
Panafcortelone
Paracortol
Paracotol
Pediapred
Poly-Pred
Precortalon
Precortancyl
Precortilon
Precortisyl
Pred Forte
Pred Mild
Predair
Predair A
Predair Forte
Predalone 50
Predalone T.B.A.
Predate
Predate Tba
Predate-50
Predcor-25
Predcor-50
Predcor-Tba
Predisolone Sodium Phosphate
Predne-Dome
Prednelan
Predni-Dome
Prednicen
Predniliderm
Predniretard
Prednis
Prednisolona
Prednisolona [INN-Spanish]
Prednisolone (JP15/USP/INN)
Prednisolone (anhydrous)
Prednisolone Acetate
Prednisolone Sodium Phosphate
Prednisolone Tebutate
Prednisolone [INN:BAN:JAN]
Prednisolonum
Prednisolonum [INN-Latin]
Predonin
Predonine
Prelone
Prenolone
Prestwick0_000274
Prestwick1_000274
Prestwick2_000274
Prestwick3_000274
Prestwick_404
Rolisone
S1737_Selleck
SAM002264639
SMR000718761
SPBio_002367
Scherisolon
Solone
Steran
Sterane
Sterolone
Supercortisol
UNII-9PHQ9Y1OLM
Ulacort
Ultra Pred
Ultracorten H
Ultracortene H
Ultracortene-H
Ultracortene-Hydrogen
Ultracortene-hydrogen
ZINC03833821
component of Ataraxoid
component of K-Predne-Dome
delta(1)-Cortisol
delta(1)-Dehydrocortisol
delta(1)-Dehydrohydrocortisone
delta(1)-Hydrocortisone
delta(sup 1)-Cortisol
delta(sup 1)-Dehydrocortisol
delta(sup 1)-Dehydrohydrocortisone
delta(sup 1)-Hydrocortisone
delta-dehydrocortisol
delta-dehydrohydrocortisone
delta-hydrocortisone
prednisolone
20
Mycophenolic acidPhase 291924280-93-1446541
Synonyms:
(e)-6-(4-Hydroxy-6-methoxy-7-methyl-3-oxo-5-phthalanyl)-4-methyl-4-hexenoic acid
Acide mycophenolique
Acido micofenolico
Acidum mycophenolicum
 
Melbex
Micofenolico acido
Mycophenoic acid
Mycophenolate
Mycophenolsäure
Myfortic
21Alkylating AgentsPhase 24573
22
AcetylcysteinePhase 2304616-91-112035
Synonyms:
(2R)-2-acetylamino-3-Sulfanylpropanoic acid
(R)-2-acetylamino-3-Mercaptopropanoic acid
(R)-Mercapturic acid
2-Acetylamino-3-mercapto-propionate
2-Acetylamino-3-mercapto-propionic acid
ACC
Acetadote
Acetilcisteina
Acetylcysteine
Acetylcysteinum
Fluimicil Infantil
Fluimucetin
Fluimucil
Flumucetin
 
Fluprowit
L-Acetylcysteine
L-alpha-acetamido-beta-Mercaptopropionic acid
Lysox
Mercapturic acid
Mucolysin
Mucomyst
N-ACETYL-L-cysteine
N-Acety-L-Cysteine
N-Acetyl-3-mercaptoalanine
N-Acetyl-L-(+)-cysteine
N-Acetylcysteine
N-acetylcysteine
NAC
Parvolex
Sodium 2-acetamido-3-mercaptopropionate
23
Glatiramer AcetatePhase 2, Phase 194147245-92-93081884
Synonyms:
(2S)-2,6-diaminohexanoic acid
(2S)-2-amino-3-(4-hydroxyphenyl)propanoic acid
(2S)-2-aminopentanedioic acid
(2S)-2-aminopropanoic acid
147245-92-9
AC1MIXQC
Aventis brand of copolymer 1
C089995
CID3081884
COP-1
Copaxone
Copolymer 1
 
Copolymer-1
Copoylmer 1
Glatiramer acetate
Glatiramer acetate [USAN]
L-Glutamic acid peptide with L-alanine, L-lysine and L-tyrosine, acetate (salt)
L-Glutamic acid polymer with L-alanine, L-lysine and L-tyrosine, acetate (salt)
LS-186971
LS-71889
TV 5010
TV-5010
TV5010
Teva brand of copolymer 1
UNII-5M691HL4BO
acetic acid
24
BenzocainePhase 217941994-09-7, 94-09-72337
Synonyms:
(p-(Ethoxycarbonyl)phenylamine
06952_FLUKA
112909_ALDRICH
112909_SIAL
1333-08-0
23239-88-5
23239-88-5 (hydrochloride)
4 Aminobenzoic Acid Ethyl Ester
4-(Ethoxycarbonyl)aniline
4-(Ethoxycarbonyl)phenylamine
4-14-00-01129 (Beilstein Handbook Reference)
4-Aminobenzoate
4-Aminobenzoic acid
4-Aminobenzoic acid ethyl ester
4-Aminobenzoic acid, ethyl ester
4-Carbethoxyaniline
4-amino-benzoic acid ethyl ester
4-aminobenzoic acid ethyl ester
71123-91-6
94-09-7
94-09-7 (Parent)
A0271
AB00051923
AC1L1DGC
AC1Q341A
AC1Q64JE
AE-562/40377256
AI3-02081
AKOS000119763
AR-1H9065
Acetate, Benzocaine
Aethoform
Aethylium paraminobenzoicum
Amben ethyl ester
Americaine
Anaesthan-syngala
Anaesthesin
Anaesthesinum
Anaesthin
Anestezin
Anestezin [Russian]
Anesthesin
Anesthesine
Anesthone
BB_SC-0019
BPBio1_001017
BRD-K75466013-001-05-2
BRN 0638434
BSPBio_000923
BSPBio_001908
Baby Anbesol
Bensokain
Benzoak
Benzocaina
Benzocaina [INN-Spanish]
Benzocaine
Benzocaine (USP/INN)
Benzocaine Acetate
Benzocaine Formate
Benzocaine Hydrobromide
Benzocaine Hydrochloride
Benzocaine Methanesulfonate
Benzocaine [INN:BAN]
Benzocainum
Benzocainum [INN-Latin]
Benzoic acid, 4-amino-, ethyl ester
Benzoic acid, 4-amino-, ethyl ester, hydrochloride
Benzoic acid, amino-, ethyl ester
Benzoic acid, p-amino-, ethyl ester
C07527
CAS-94-09-7
CHEBI:116735
CHEMBL278172
CID2337
Caswell No. 430A
Chloraseptic
D001566
D00552
DB01086
Dermoplast
Diet Ayds
DivK1c_000932
E1501_SIGMA
EINECS 202-303-5
EPA Pesticide Chemical Code 097001
ETHYL-P-AMINOBENZOATE
Ethoform
Ethoforme
Ethyl 4-aminobenzoate
Ethyl 4-aminobenzoate hydrochloride
Ethyl 4-aminobenzoic acid
Ethyl Aminobenzoate
Ethyl PABA
 
Ethyl aminobenzoate
Ethyl aminobenzoate (JP15)
Ethyl aminobenzoate (VAN)
Ethyl aminobenzoic acid
Ethyl p-Aminobenzoate
Ethyl p-Aminophenylcarboxylate
Ethyl p-aminobenzenecarboxylate
Ethyl p-aminobenzoate
Ethyl p-aminobenzoic acid
Ethyl p-aminophenylcarboxylate
Ethylester kyseliny p-aminobenzoove
Ethylester kyseliny p-aminobenzoove [Czech]
Ethylis aminobenzoas
Formate, Benzocaine
HMS1570O05
HMS1920G09
HMS2091M11
HMS502O14
HSDB 7225
Hurricaine
Hydrobromide, Benzocaine
Hydrochloride, Benzocaine
I05-0204
IDI1_000932
Identhesin
KBio1_000932
KBio2_000474
KBio2_003042
KBio2_005610
KBio3_001408
KBioGR_000658
KBioSS_000474
Keloform
LS-35847
MLS001331704
MLS002153970
Methanesulfonate, Benzocaine
MolPort-000-871-526
NCGC00016352-01
NCGC00094598-01
NCGC00094598-02
NINDS_000932
NSC 122792
NSC 41531
NSC41531
NSC4688
Norcain
Norcaine
Norcainum
Oprea1_750694
Oprea1_827402
Ora-jel
Orabase-B
Orthesin
Otocain
Outgro
Parathesin
Parathesin (TN)
Parathesine
Prestwick0_000712
Prestwick1_000712
Prestwick2_000712
Prestwick3_000712
Prestwick_991
SMR000059025
SPBio_000134
SPBio_002844
SPECTRUM1500139
STK043620
Slim Mint Gum
Solarcaine
Solu H
Spectrum2_000117
Spectrum3_000314
Spectrum4_000249
Spectrum5_000860
Spectrum_000074
Topcaine
UNII-U3RSY48JW5
WLN: ZR DVO2
ZINC12358719
benzocaine
ethylaminobenzoate-4
h-4-abz-oet
nchembio.182-comp4
p-(Ethoxycarbonyl)aniline
p-Aminobenzoate
p-Aminobenzoic acid
p-Aminobenzoic acid ethyl ester
p-Aminobenzoic acid, ethyl ester
p-Aminobenzoic ethyl ester
p-Carbethoxyaniline
p-Ethoxycarboxylic Aniline
p-Ethoxycarboxylic aniline
25insulinPhase 24401
26
BusulfanPhase 253255-98-12478
Synonyms:
1, 4-Dimethanesulfonoxybutane
1, 4-Dimethylsulfonoxybutane
1, {4-Bis[methanesulfonoxy]butane}
1,4-BUTANEDIOL DIMETHANESULFONATE
1,4-Bis(methanesulfonoxy)butane
1,4-Bis(methanesulfonyloxy)butane
1,4-Bis[methanesulfonoxy]butane
1,4-Butanedi yl dimethanesulfonate
1,4-Butanediol dimethanesulfonate
1,4-Butanediol dimethanesulphonate
1,4-Butanediol dimethylsulfonate
1,4-Butanediol, dimethanesulfonate
1,4-Butanediol, dimethanesulphonate
1,4-Butanediyl dimethanesulfonate
1,4-Di(methylsulfonoxy)butane
1,4-Dimesyloxybutane
1,4-Dimethane sulfonyl oxybutane
1,4-Dimethanesulfonoxybutane
1,4-Dimethanesulfonoxylbutane
1,4-Dimethanesulfonyloxybutane
1,4-Dimethanesulphonyloxybutane
1,4-Dimethylsulfonoxybutane
1,4-Dimethylsulfonyloxybutane
2041 C. B
2041 C. B.
2041 C.B
2041 C.B.
4-((Methylsulfonyl)oxy)butyl methanesulfonate
4-methylsulfonyloxybutyl methanesulfonate
55-98-1
AC-198
AC1L1DRQ
AC1Q4GRQ
AI3-25012
AKOS003614975
AN 33501
Ambap55-98-1
B1022
B2635_FLUKA
B2635_SIGMA
BRN 1791786
BSPBio_001920
BUSULFAN (1,4-BUTANEDIOL, DIMETHANESULFONATE)
Bisulfex
Busilvex
Busulfan
Busulfan (JP15/USP/INN)
Busulfan GlaxoSmithKline Brand
Busulfan Orphan Brand
Busulfan Wellcome
Busulfan Wellcome Brand
Busulfan [INN:JAN]
Busulfano
Busulfano [INN-Spanish]
Busulfanum
Busulfanum [INN-Latin]
Busulfex
Busulphan
Busulphane
Butanedioldimethanesulfonate
Buzulfan
C.B. 2041
C6H14O6S2
CB 2041
CCRIS 418
CHEBI:28901
CHEMBL820
CID2478
CPD000058613
Citosulfan
D002066
D00248
DB01008
DivK1c_000847
EINECS 200-250-2
FT-0083567
G.T. 41
GT 2041
GT 41
Glaxo Wellcome Brand of Busulfan
GlaxoSmithKline Brand of Busulfan
Glyzophrol
HMS1920I07
HMS2091O09
HMS502K09
 
HSDB 7605
I09-1371
IDI1_000847
InChI=1/C6H14O6S2/c1-13(7,8)11-5-3-4-6-12-14(2,9)10/h3-6H2,1-2H3
KBio1_000847
KBio2_000512
KBio2_003080
KBio2_005648
KBio3_001420
KBioGR_000698
KBioSS_000512
LS-1358
Leucosulfan
MLS001076666
MYLERAN (TN)
Mablin
Methanesulfonic
Methanesulfonic acid, tetram ethylene ester
Methanesulfonic acid, tetramethylene ester
Mielevcin
Mielosan
Mielucin
Milecitan
Mileran
Misulban
Mitosan
Mitostan
MolPort-001-783-406
Myeleukon
Myeloleukon
Myelosan
Myelosanum
Mylecytan
Myleran
Myleran Tablets
Myleran tablets
Myleran, Busulfex, Busulfan
Mylerlan
NCGC00090905-01
NCGC00090905-02
NCGC00090905-03
NCGC00090905-04
NCGC00090905-05
NCGC00090905-06
NCGC00090905-07
NCI-C01592
NCI60_041640
NCIMech_000192
NINDS_000847
NSC 750
NSC-750
NSC-750sulphabutin
NSC750
Orphan Brand of Busulfan
Prestwick_989
S1692_Selleck
SAM002554887
SMR000058613
SPBio_000253
SPECTRUM1500152
ST50825921
Spectrum2_000067
Spectrum3_000320
Spectrum4_000259
Spectrum5_000928
Spectrum_000092
Sulfabutin
Sulfabutin (VAN)
Sulphabutin
Tetramethylene Dimethane Sulfonate
Tetramethylene bis(methanesulfonate)
Tetramethylene bis[methanesulfonate]
Tetramethylene dimethane sulfonate
Tetramethylene {bis[methanesulfonate]}
Tetramethylenester Kyseliny Methansulfonove
Tetramethylenester kyseliny methansulfonove
Tetramethylenester kyseliny methansulfonove [Czech]
UNII-G1LN9045DK
WLN: WS1&O4OSW1
Wellcome Brand of Busulfan
Wellcome, Busulfan
X 149
acid, tetramethylene ester
alkylating agent: crosslinks guanine residues
busulfan
butane-1,4-diyl dimethanesulfonate
n-Butane-1,3-di(methylsulfonate)
27
FludarabinePhase 2109221679-14-1, 75607-67-930751
Synonyms:
(2R,3S,4S,5R)-2-(6-amino-2-fluoro-9H-purin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol
(2R,3S,4S,5R)-2-(6-amino-2-fluoropurin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol
2-F-ARAA
2-F-ara-A
2-Fluoro Ara-A
2-Fluoro-9-beta-D-arabinofuranosyladenine
2-fluoro ARA-A
21679-14-1
9-beta-D-Arabinofuranosyl-2-fluoroadenine
9-beta-D-arabinofuranosyl-2-fluoro-9H-purin-6-amine
9H-Purin-6-amine, 9-beta-D-arabinofuranosyl-2-fluoro- (9CI)
AC1LCW8I
AC1Q51CF
C10H12FN5O4
CCRIS 3382
CHEMBL1568
CID657237
CPD000058874
D07966
EINECS 244-525-5
F-Ara-A
FAMP
FT-0082766
FaraA
Fludara
Fludara, Fludarabine
 
Fludarabina
Fludarabina [Spanish]
Fludarabine
Fludarabine (INN)
Fludarabine 5'-monophosphate
Fludarabine [INN]
Fludarabine monophosphate
Fludarabine phosphate
Fludarabinum
Fludarabinum [Latin]
Fludura
Fluradosa
Fluradosa (TN)
HSDB 6964
I14-4978
LS-15061
MLS000028687
NSC 118218
NSC 118218H
NSC-118218
S1491_Selleck
SAM002548956
SMR000058874
SQ Fludarabine
UNII-1X9VK9O1SC
UNII-P2K93U8740
ZINC04216238
28
CyclophosphamidePhase 2275650-18-0, 6055-19-22907
Synonyms:
(+-)-Cyclophosphamide
(-)-Cyclophosphamide
(RS)-Cyclophosphamide
1-(bis(2-chloroethyl)amino)-1-oxo-2-aza-5-oxaphosphoridine
1-Bis(2-chloroethyl)amino-1-oxo-2-aza-5-oxaphosphoridin
2-[Bis(2-chloroethylamino)]-tetrahydro-2H-1,3,2-oxazaphosphorine-2-oxide
4-Hydroxy-cyclophosphan-mamophosphatide
50-18-0
60007-95-6
6055-19-2 (monohydrate)
75526-90-8
AC1L1EQQ
AI3-26198
ASTA
ASTA B518
Anhydrous cyclophosphamide
Asta B 518
B 518
B-518
BRN 0011744
BSPBio_002099
Bis(2-chloroethyl)phosphoramide cyclic propanolamide ester
C 0768
C07888
C7H15Cl2N2O2P
CB 4564
CB-4564
CCRIS 188
CHEBI:4027
CHEMBL32520
CHEMBL88
CID2907
CP
CPA
CTX
CY
Ciclofosfamida
Ciclofosfamida [INN-Spanish]
Ciclofosfamide
Ciclophosphamide
Ciclophosphamide [INN]
Clafen
Claphene
Cycloblastin
Cyclophosphamid
Cyclophosphamide
Cyclophosphamide (INN)
Cyclophosphamide (TN)
Cyclophosphamide (anhydrous form)
Cyclophosphamide (anhydrous)
Cyclophosphamide Monohydrate
Cyclophosphamide Sterile
Cyclophosphamide anhydrous
Cyclophosphamide, (+-)-Isomer
Cyclophosphamides
Cyclophosphamidum
Cyclophosphamidum [INN-Latin]
Cyclophosphan
Cyclophosphane
Cyclophosphanum
Cyclophosphoramide
Cyclostin
Cyklofosfamid
Cyklofosfamid [Czech]
Cytophosphan
Cytophosphane
Cytoxan
Cytoxan (TN)
Cytoxan Lyoph
D,L-Cyclophosphamide
D07760
 
DB00531
DivK1c_000246
EINECS 200-015-4
EU-0100238
Endoxan
Endoxan R
Endoxan-Asta
Endoxana
Endoxanal
Endoxane
Enduxan
Genoxal
HMS2090A12
HSDB 3047
Hexadrin
IDI1_000246
KBio1_000246
KBio2_001338
KBio2_003906
KBio2_006474
KBio3_001319
KBioGR_000888
KBioSS_001338
LS-1302
LS-99787
Ledoxina
Lopac-C-0768
Lopac0_000238
Lyophilized Cytoxan
Mitoxan
MolPort-001-783-420
N,N-Bis(2-chloroethyl)-1,3,2-oxazaphosphinan-2-amine 2-oxide
N,N-Bis(2-chloroethyl)tetrahydro-2H-1,3,2-oxazaphosphorin-2-amine 2-oxide
NCGC00015209-01
NCGC00015209-03
NCGC00015209-06
NCGC00091741-02
NCGC00091741-03
NCI-C04900
NCI60_002097
NINDS_000246
NSC 26271
NSC-26271
NSC26271
NSC273033
NSC273034
Neosar
Occupation, cyclophosphamide exposure
Procytox
RCRA waste no. U058
Rcra Waste Number U058
Rcra waste number U058
Revimmune
S1217_Selleck
SK 20501
SPBio_001071
STK177249
STOCK2S-91217
Semdoxan
Sendoxan
Senduxan
Spectrum2_001146
Spectrum3_000370
Spectrum4_000304
Spectrum5_000795
Spectrum_000858
UNII-6UXW23996M
WLN: T6MPOTJ BO BN2G2G
Zyklophosphamid
Zyklophosphamid [German]
bis(2-Chloroethyl)phosphami de cyclic propanolamide
bis(2-Chloroethyl)phosphamide cyclic propanolamide ester
cyclophosphamide
29
CelecoxibPhase 2427169590-42-52662
Synonyms:
169590-42-5
184007-95-2
1oq5
4-(5-(4-Methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl)benzenesulfonamide
4-[5-(4-METHYLPHENYL)-3-(TRIFLUOROMETHYL)-1H-PYRAZOL-1-YL]BENZENESULFONAMIDE
4-[5-(4-methylphenyl)-3-(trifluoromethyl)-1Hpyrazol-1-yl] benzenesulfonamide
4-[5-(4-methylphenyl)-3-(trifluoromethyl)pyrazol-1-yl]benzenesulfonamide
AC-4228
AC1L1E6K
AI-525
BIDD:GT0408
BRD-K02637541-001-02-4
BSPBio_003596
Benzenesulfonamide,4-(5-(4-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl)
C07589
C105934
C17H14F3N3O2S
CCRIS 8679
CEL
CEP-33222
CHEBI:41423
CHEMBL118
CID2662
CPD000550473
Celebra
Celebrex
Celebrex (TN)
Celebrex, Celebra, Celecoxib
Celecox
Celecoxi
Celecoxib
Celecoxib (JAN/USAN/INN)
Celecoxib (SC-58635)
Celecoxib [Old RN]
Celecoxib [USAN]
Celecoxibum
Celocoxib
Célécoxib
D00567
DB00482
DivK1c_000893
Eurocox
FT-0080064
HMS1922G14
HMS2089L18
HMS2093I07
HMS502M15
HSDB 7038
I01-1033
IDI1_000893
KBio1_000893
KBio2_000912
 
KBio2_002351
KBio2_003480
KBio2_004919
KBio2_006048
KBio2_007487
KBio3_002830
KBio3_003037
KBioGR_000723
KBioGR_002351
KBioSS_000912
KBioSS_002354
LS-31667
MLS001165684
MLS001195656
MLS001304708
Medicoxib
MolPort-002-885-815
NCGC00091455-01
NCGC00091455-02
NCGC00091455-03
NCGC00091455-04
NCI60_041049
NINDS_000893
NSC719627
Onsenal
P-(5-P-Tolyl-3-(trifluoromethyl)pyrazol-1-yl)benzenesulfonamide
Pfizer brand of celecoxib
S1261_Selleck
SAM002589995
SC 58635
SC-58553, SC-58635
SC-58635
SC58635
SMR000550473
SPBio_001512
SPECTRUM1503678
Solexa
Spectrum2_001576
Spectrum3_001996
Spectrum4_000182
Spectrum5_001324
Spectrum_000432
TL8001323
TPI-336
UNM-0000305813
Xilebao
YM 177
YM-177
YM177
ZINC02570895
cMAP_000027
celecoxib
p-(5-p-Tolyl-3-(trifluoromethyl)pyrazol-1-yl)benzenesulfonamide
30
ZincPhase 221547440-66-632051, 23994
Synonyms:
30Zn
Cinc
Zinc
Zinc ion
 
Zincum
Zink
Zn
Zn(ii)
Zn2+
31TocotrienolNutraceuticalPhase 2391
32
vitamin eNutraceuticalPhase 239259-02-914985
Synonyms:
(+)-a-Tocopherol
(+)-alpha-Tocopherol
(+)-α-tocopherol
(2R)-2,5,7,8-TETRAMETHYL-2-[(4R,8R)-4,8,12-TRIMETHYLTRIDECYL]CHROMAN-6-OL
(2R)-3,4-Dihydro-2,5,7,8-tetramethyl-2-[(4R,8R)-4,8,12-trimethyltridecyl]-2H-1-benzopyran-6-ol
(2R,4'R,8'R)-a-Tocopherol
(2R,4'R,8'R)-alpha-Tocopherol
(2R,4'R,8'R)-α-tocopherol
(R,R,R)-a-Tocopherol
(R,R,R)-alpha-Tocopherol
(R,R,R)-α-tocopherol
5,7,8-Trimethyltocol
5,7,8-trimethyltocol
Amino-Opti-E
Aquasol E
D-alpha-Tocopherol
Daltose
Denamone
E-200 I.U. Softgels
 
E-Complex-600
E-Ferol
E-Vitamin succinate
Eprolin
Gordo-Vite E
Phytogermin
Phytogermine
RRR-alpha-tocopherol
RRR-alpha-tocopheryl
Tocopherol
Vitamin E
Vitamin Ea
Vitamin Plus E Softgells
Vitec
a-D-Tocopherol
a-Tocopherol
alpha-Tocopherol
alpha-delta-Tocopherol
alpha-tocopherol
d-α-tocopherol
delta-alpha-Tocopherol
33FolateNutraceuticalPhase 24143
34tannic acidNutraceuticalPhase 21794
35
Folic AcidNutraceuticalPhase 2414359-30-36037
Synonyms:
(2S)-2-[[4-[(2-amino-4-oxo-1H-pteridin-6-yl)methylamino]benzoyl]amino]pentanedioic acid
01769_FLUKA
2d0k
33609-88-0
36653-55-1 (mono-potassium salt)
59-30-3
6484-89-5 (mono-hydrochloride salt)
AC-11682
AC1L1LNX
AI3-26387
AKOS000503224
ARONIS014410
Acfol (Spain)
Acide folique
Acide folique [INN-French]
Acido folico
Acido folico [INN-Spanish]
Acidum folicum
Acidum folicum [INN-Latin]
Acifolic
Antianemia factor
Apo-Folic
BIDD:ER0563
BIDD:GT0641
BIF0608
BPBio1_000654
BSPBio_000594
BSPBio_002338
C00504
C20H20N6O6
CAS-59-30-3
CCRIS 666
CHEBI:27470
CHEMBL1622
CID6037
CPD000471860
Cytofol
D00070
DB00158
DivK1c_000494
Dosfolat B activ
EINECS 200-419-0
F0043
F7876_SIAL
F7876_SIGMA
F8758_SIGMA
F8798_SIAL
F8890_SIGMA
FOL
Facid
Factor U
Folacid
Folacin
Folaemin
Folaemin [Netherlands]
Folan
Folasic (Australia)
Folate
Folbal
Folcidin
Folcidin (VAN)
Folcysteine
Foldine
Foldine [France]
Folettes
Foliamin
Folic
Folic acid
Folic acid (JP15/USP/INN)
Folic acid (TN)
Folic acid [BAN:INN:JAN]
Folic acid [INN:BAN:JAN]
Folic acid dihydrate
Folicet
Folicet (TN)
Folico
Folico (Italy)
Folina
Folina (Italy)
Folipac
Folsaeure
 
Folsan
Folsaure
Folsav
Folvite
Folvron
Glutamic acid, N-(p-(((2-amino-4-hydroxypyrimido(4,5-b)pyrazin-6-yl)methyl)amino)benzoyl)-, L
HMS1921D20
HMS2092N17
HMS501I16
HSDB 2002
IDI1_000494
InChI=1/C19H19N7O6/c20-19-25-15-14(17(30)26-19)23-11(8-22-15)7-21-10-3-1-9(2-4-10)16(29)24-12(18(31)32)5-6-13(27)28/h1-4,8,12,21H,5-7H2,(H,24,29)(H,27,28)(H,31,32)(H3,20,22,25,26,30)/t12-/m0/s
Incafolic
KBio1_000494
KBio2_001861
KBio2_004429
KBio2_006997
KBio3_001558
KBioGR_002222
KBioSS_001861
Kyselina listova
Kyselina listova [Czech]
LS-2157
Liver Lactobacillus casei factor
MLS001304016
MLS001335861
Millafol
Mission prenatal
Mittafol
MolPort-004-285-551
N-(4-(((2-Amino-1,4-dihydro-4-oxo-6-pteridinyl)methyl)amino)benzo- yl)-L-glutamic acid
N-(4-((2-Amino-1,4-dihydro-4-oxo-6-pteridinyl)methyl)amino)benzoyl)-L-glutamic acid
N-(4-{[(2-Amino-4-oxo-3,4-dihydropteridin-6-yl)methyl]amino}benzoyl)-L-glutamic acid
N-(4-{[(2-amino-4-oxo-1,4-dihydropteridin-6-yl)methyl]amino}benzoyl)-L-glutamic acid
N-(p-(((2-Amino-4-hydroxy-6-pteridinyl)methyl)amino)benzoyl)-L-glutamic acid
N-Pteroyl-L-glutamic acid
N-[(4-{[(2-Amino-4-oxo-1,4-dihydropteridin-6-yl)methyl]amino}phenyl)carbonyl]-L-glutamic acid
N-[(4-{[(2-amino-4-oxo-1,4-dihydropteridin-6-yl)methyl]amino}phenyl)carbonyl]-L-glutamic acid
N-[4-[[(2-Amino-3,4-dihydro-4-oxo-6-pteridinyl)methyl]amino]benzoyl]-L-glutamic acid
NCGC00016265-01
NCGC00142391-01
NINDS_000494
NSC 3073
Nifolin
Nifolin [Denmark]
Novofolacid
Novofolacid [Canada]
PGA
PGA (VAN)
Prestwick3_000627
Prestwick_230
PteGlu
Pteroyl-L-glutamate
Pteroyl-L-glutamic acid
Pteroyl-L-monoglutamate
Pteroyl-L-monoglutamic acid
Pteroylglutamate
Pteroylglutamic acid
Pteroylmonoglutamate
Pteroylmonoglutamic acid
SAM002264616
SDCCGMLS-0066738.P001
SMP2_000137
SMR000471860
SPBio_001357
SPECTRUM1502020
Serum Folate Level
Spectrum2_001459
Spectrum3_000749
Spectrum4_001751
Spectrum5_000602
Spectrum_001381
UNII-935E97BOY8
Usaf cb-13
Vitamin B11
Vitamin B9
Vitamin Bc
Vitamin Be
Vitamin M
bmse000299
folic acid
nchembio.108-comp10
36TocopherolNutraceuticalPhase 2395
37
KetaminePhase 14966740-88-13821
Synonyms:
(+-)-Ketamine
(+/-)-2-(2-Chlorophenyl)-2-(methylamino)cyclohexanone
(+/-)-2-(o-Chlorophenyl)-2-(methylamino)cyclohexanone
(+/-)-Ketamine
(-)-Ketamine
(S)-(-)-Ketamine
(S)-Ketamine
(±)-ketamine
100477-72-3
2-(2-Chloro-phenyl)-2-methylamino-cyclohexanone
2-(2-Chlorophenyl)-2-(methylamino)cyclohexanone
2-(2-chlorophenyl)-2-(methylamino)cyclohexan-1-one
2-(Methylamino)-2-(2-chlorophenyl)cyclohexanone
2-(methylamino)-2-(2-chlorophenyl)cyclohexanone
2-(o-Chlorophenyl)-2-(methylamino)-cyclohexanone
2-(o-Chlorophenyl)-2-(methylamino)cyclohexanone
2-(o-chlorophenyl)-2-(methylamino)-cyclohexanone
33643-45-7
6740-88-1
79499-51-7
AC1L1GSH
AC1Q40UR
AKOS001053247
BRN 2216965
C07525
C13H16ClNO
CHEBI:138833
CHEBI:6121
CHEMBL742
CI 581 base
CI-581
CID3821
CLSTA 20
Calypsol
Cetamina
Cetamina [INN-Spanish]
Cyclohexanone, 2-(2-chlorophenyl)-2-(methylamino)- (9CI)
Cyclohexanone, 2-(2-chlorophenyl)-2-(methylamino)-, (+-)- (9CI)
Cyclohexanone, 2-(o-chlorophenyl)-2-(methylamino)-, (+/-)- (8CI)
D08098
DB01221
DEA No. 7285
 
DL-ketamine
DivK1c_000217
EINECS 229-804-1
Esketamine
Green
IDI1_000217
KBio1_000217
KETAMINE
KETAMINE HCL
Ketaject
Ketalar
Ketalar base
Ketamina
Ketamine (INN)
Ketamine Base
Ketamine HCL
Ketamine [INN:BAN]
Ketaminum
Ketaminum [INN-Latin]
Ketanest
Ketoject
Ketolar
L-Ketamine
LS-57301
MLS001331674
MolPort-001-838-070
NCGC00159480-02
NCGC00159480-03
NINDS_000217
NMDA
NSC 70151
NSC70151
SMR000238141
Special K
Special K [street name]
Special k
T385
Tekam
Tekam (TN)
UNII-690G0D6V8H
dl-Ketamine
ketamine
l-Ketamine
38
Topiramate24497240-79-45284627
Synonyms:
-D-fructopyranose deriv.
.beta.-D-Fructopyranose, 2,3:4,5-bis-O-(1-methylethylidene)-, sulfamate (9CI)
2,3-4,5-bis-O-(1-methylethylidene)-beta-D-fructopyranose sulfamate
2,3:4,5-Bis-O-(1-methylethylidene) .beta.-D-fructopyranose sulfamate
2,3:4,5-Bis-O-(1-methylethylidene)-36-D-fructo-pyranose sulfamate
2,3:4,5-Bis-O-(1-methylethylidene)-beta-D-fructopyranose sulfamate
2,3:4,5-Di- O -isopropylidene-(beta)-D-fructopyranose sulfamate
2,3:4,5-Di-O-isopropylidene-beta-D-fructopyranose sulfamate
5H-Bis[1,3]dioxolo[4,5-b:4',5'-d]pyran, .beta.
97240-79-4
AKOS000424547
BIDD:GT0854
BIDD:PXR0127
BRN 5988957
BSPBio_002306
C052342
C07502
C12H21NO8S
CBChromo1_000352
CHEBI:129573
CHEMBL220492
CID5284627
CPD000466325
Cilag brand of topiramate
D00537
DB00273
Epitoma
Epitomax
HMS1922H06
HMS2051L09
HMS2093D20
HSDB 7531
Janssen brand of topiramate
KS-1122
KW-6485
LS-187392
LS-69764
MLS000759431
MLS001424070
McN 4853
McN-4853
MolPort-001-615-062
MolPort-002-885-869
NCGC00178714-01
 
Ortho brand of topiramate
RWJ 17021
RWJ-17021
RWJ-17021-000
S1438_Selleck
SAM001246601
SMR000466325
SPBio_000995
SPECTRUM1505801
STOCK1N-71037
Spectrum2_001128
T0575_SIGMA
TL8006021
TOR
TPM
Tipiramate
Tipiramate [French]
Tipiramato
Tipiramato [Spanish]
Topamac
Topamax
Topamax (TN)
Topamax Sprinkle
Topamax, Topiramate
Topimax
Topina
Topiramate
Topiramate (JAN/USAN/INN)
Topiramate (TPM)
Topiramate / Placebo
Topiramate [USAN:BAN:INN]
Topiramato
Topiramato [INN-Spanish]
Topiramatum
Topiramatum [INN-Latin]
Topiramic acid
Topomax
UNII-0H73WJJ391
USL-255
[(3aS,5aR,8aR,8bS)-2,2,7,7-tetramethyltetrahydro-3aH-bis[1,3]dioxolo[4,5-b:4',5'-d]pyran-3a-yl]methyl sulfamate
beta-D-Fructopyranose, 2,3:4,5-bis-O-(1-methylethylidene)-, sulfamate
beta.-D-Fructopyranose, 2,3:4,5-bis-O-(1-methylethylidene)-, 1-sulfamate
topiramate
topiramate tablet
topiramatum [Latin]
39
Heparin7799005-49-6772, 46507594
Synonyms:
101921-26-0
102-94-3
102785-31-9
104521-37-1
11078-24-3
11129-39-8
12656-11-0
2-o-sulfohexopyranuronosyl-(1->4)-2-deoxy-3-o-sulfo-2-(sulfoamino)hexopyranosyl-(1->4)-2-o-sulfohexopyranuronosyl-(1->4)-2-acetamido-2-deoxy-6-o-sulfohexopyranose
37324-73-5
6-[6-[6-[5-acetamido-4,6-dihydroxy-2-(sulfooxymethyl)oxan-3-yl]oxy-2-carboxy-4-hydroxy-5-sulfooxyoxan-3-yl]oxy-2-(hydroxymethyl)-5-(sulfoamino)-4-sulfooxyoxan-3-yl]oxy-3,4-dihydroxy-5-sulfooxyoxane-2-carboxylic acid
9041-08-1
9045-22-1
9075-96-1
913079-23-9
91449-79-5
AC1L19ZN
AC1L1ROY
ALFA 87-120
ALFA 87-163
ALFA 87-198
ALFA 87-81
ALFA 88-247
AR-1E4539
Allocinnamic acid
Ardeparin
Ardeparin sodium
Arteven
Bemiparin
Bemiparin sodium
CID772
CID8784
CY 216
Calciparine
Certoparin
Clexane
Clivarin
Clivarine
Cy 222
D006495
D017984
DB00407
DB01225
Dalteparin
Dalteparin sodium
Depo-Heparin
EINECS 232-681-7
EMT 966
EMT 967
EMT-966
EMT-967
EMT966
EMT967
Enoxaparin
Enoxaparin sodium
Enoxaparine
Eparina
Eparina [DCIT]
FR 860
Fluxum
Fragmin A
Fragmin B
Fragmin IV
Fraxiparin
H 2149
HSDB 3094
Hed-heparin
Hep Flush Kit in plastic container
Hep-Lock
Hep-Lock U/P
Hep-lock
Heparin
Heparin CY 216
Heparin Lock Flush
Heparin Lock Flush in plastic container
Heparin Lock Flush preservative free
Heparin Lock Flush preservative free in plastic container
Heparin Sodium
Heparin natrium
Heparin sodium
Heparin sodium 1,000 units and sodium chloride 0.9% in plastic container
Heparin sodium 1,000 units in dextrose 5% in plastic container
Heparin sodium 1,000 units in sodium chloride 0.9% in plastic container
Heparin sodium 10,000 units in dextrose 5%
Heparin sodium 10,000 units in dextrose 5% in plastic container
Heparin sodium 10,000 units in sodium chloride 0.45%
Heparin sodium 10,000 units in sodium chloride 0.9%
Heparin sodium 12,500 units in dextrose 5%
Heparin sodium 12,500 units in dextrose 5% in plastic container
Heparin sodium 12,500 units in sodium chloride 0.45% in plastic container
Heparin sodium 12,500 units in sodium chloride 0.9%
Heparin sodium 2,000 units and sodium chloride 0.9% in plastic container
Heparin sodium 2,000 units in dextrose 5% in plastic container
Heparin sodium 2,000 units in sodium chloride 0.9% in plastic container
Heparin sodium 20,000 units and dextrose 5% in plastic container
Heparin sodium 20,000 units in dextrose 5% in plastic container
Heparin sodium 25,000 units and dextrose 5% in plastic container
 
Heparin sodium 25,000 units in dextrose 5%
Heparin sodium 25,000 units in dextrose 5% in plastic container
Heparin sodium 25,000 units in sodium chloride 0.45% in plastic container
Heparin sodium 25,000 units in sodium chloride 0.9%
Heparin sodium 25,000 units in sodium chloride 0.9% in plastic container
Heparin sodium 5,000 units and sodium chloride 0.9% in plastic container
Heparin sodium 5,000 units in dextrose 5% in plastic container
Heparin sodium 5,000 units in sodium chloride 0.45%
Heparin sodium 5,000 units in sodium chloride 0.9%
Heparin sodium 5,000 units in sodium chloride 0.9% in plastic container
Heparin sodium in plastic container
Heparin sodium preservative Free
Heparin sulfate
Heparin sulphate
Heparin, Low Molecular Weight
Heparin, Low-Molecular-Weight
Heparin, sodium salt
Heparina
Heparina [INN-Spanish]
Heparinate
Heparine
Heparine [INN-French]
Heparinic acid
Heparinsodiumsalt
Heparinum
Heparinum [INN-Latin]
Heparinum natricum
Hepathrom
Hepflush-10
Inno-Hep
Innohep
Isocinnamic acid
KB 101
Kabi 2165
LHN 1
LMWH
Lioton 1000
Lipo-hepin
Liquaemin
Liquaemin Lock Flush
Liquaemin Sodium
Liquaemin sodium preservative free
Liquemin
Logiparin
Lovenox
Lovenox HP
Low Molecular Weight Heparin
Low molecular weight heparin
Low molecular weight heparin sodium
Low-Molecular-Weight Heparin
Minolteparin sodium
MolPort-003-760-257
Multiparin
NSC174025
Nadroparin
Nadroparine
Novoheparin
OP 386
OP 622
Octaparin
PK 10,169
PK-10,169
PK-10169
PK10,169
PK10169
Pabyrin
Panheprin
Parnaparin
Parnaparin sodium
Parvoparin
Pularin
Reviparin
Reviparin sodium
Ro 11
Sandoparin
Sodium acid heparin
Sodium heparin
Sodium heparinate
Subeparin
Sublingula
Thromboliquine
Tinzaparin
Tinzaparin sodium
Triofiban
UNII-12M44VTJ7B
UNII-3S182ET3UA
UNII-E47C0NF7LV
UNII-T2410KM04A
UNII-ZZ45AB24CA
Unfractionated heparin
Vetren
Vitrum AB
WY 90493RD
alpha-Heparin
cis-.beta.-Carboxystyrene
cis-Cinnamic acid
enoxaparin
heparin
40calcium heparin779
41
CreatineNutraceutical11057-00-1586
Synonyms:
((amino(Imino)methyl)(methyl)amino)acetic acid
((amino(imino)methyl)(methyl)amino)acetate
((amino(imino)methyl)(methyl)amino)acetic acid
(N-methylcarbamimidamido)acetic acid
(alpha-Methylguanido)acetate
(alpha-Methylguanido)acetic acid
(α-methylguanido)acetic acid
Cosmocair C 100
Creatin
Creatine
Creatine hydrate
Kreatin
 
Krebiozon
Methylglycocyamine
Methylguanidoacetate
Methylguanidoacetic acid
N-(Aminoiminomethyl)-N-Methyl-Glycine
N-(aminoiminomethyl)-N-methylglycine
N-Amidinosarcosine
N-Carbamimidoyl-N-methylglycine
N-Methyl-N-guanylglycine
N-[(e)-AMINO(imino)methyl]-N-methylglycine
Phosphagen
[[Amino(imino)methyl](methyl)amino]acetate
[[Amino(imino)methyl](methyl)amino]acetic acid
alpha-Methylguanidino acetic acid

Interventional clinical trials:

(show all 40)
idNameStatusNCT IDPhase
1A Study of the Effectiveness and Safety of Risperidone Versus Placebo in the Treatment of Children With Autistic Disorder and Other Pervasive Developmental Disorders (PDD)CompletedNCT00261508Phase 3
2Evaluation of the Efficacy, Safety, and Tolerability of Sarizotan in Rett Syndrome With Respiratory SymptomsRecruitingNCT02790034Phase 2, Phase 3
3Independent Studies of Dextromethorphan and of Donepezil Hydrochloride for Rett SyndromeRecruitingNCT00069550Phase 3
4Phase 2 Study of EPI-743 for Treatment of Rett SyndromeCompletedNCT01822249Phase 2
5Treatment of Rett Syndrome With rhIGF-1 (Mecasermin [rDNA]Injection)CompletedNCT01253317Phase 1, Phase 2
6Pilot Study of the Effects of the Desipramine on the Neurovegetative Parameters of the Child With Rett SyndromeCompletedNCT00990691Phase 2
7A Safety Study of NNZ-2566 in Patients With Rett SyndromeCompletedNCT01703533Phase 2
8Pharmacological Treatment of Rett Syndrome With StatinsCompletedNCT02563860Phase 2
9Treatment of Rett Syndrome With Recombinant Human IGF-1RecruitingNCT01777542Phase 2
10A Safety Study of NNZ-2566 in Pediatric Rett SyndromeRecruitingNCT02715115Phase 2
11Placebo Controlled Trial of Dextromethorphan in Rett SyndromeRecruitingNCT01520363Phase 2
12Treatment of Mitochondrial Dysfunction in Rett Syndrome With TriheptanoinRecruitingNCT02696044Phase 2
13MT2013-31: Allo HCT for Metabolic Disorders and Severe OsteopetrosisRecruitingNCT02171104Phase 2
14Study to Assess Safety and Efficacy of Fingolimod in Children With Rett SyndromeActive, not recruitingNCT02061137Phase 1, Phase 2
15Pharmacological Treatment of Rett Syndrome With Glatiramer Acetate (Copaxone)Active, not recruitingNCT02153723Phase 2
16Trial of Dextromethorphan in Rett SyndromeTerminatedNCT00593957Phase 2
17An Exploratory Open Label Study of EPI-743 (Vincerinone TM) in Children With Autism Spectrum DisorderWithdrawnNCT02226458Phase 2
18An Open Label, Exploratory Study to Investigate the Treatment Effect of Glatiramer Acetate on Girls Woth Rett SyndromeRecruitingNCT02023424Phase 1
19An Exploratory Trial of Ketamine for the Treatment of Rett SyndromeActive, not recruitingNCT02562820Phase 1
20Sleep Abnormalities in Rare Genetic Disorders: AS, RTT, and PWCompletedNCT02670694
21Creatine Metabolism in Rett SyndromeCompletedNCT01198015
22Effects of Creatine Supplementation in Rett SyndromeCompletedNCT01147575
23Metabolic Evaluation of Nutrition in Rett SyndromeCompletedNCT00786071
24Genetic and Physical Characteristics of Rett SyndromeCompletedNCT00299312
25Functional Abilities in Rett SyndromeCompletedNCT00630422
26The Role of Family Functioning in Adaptation to Being a Caregiver of an Individual With Rett SyndromeCompletedNCT00891956
27New Genes Involved in Molecular Etiology of Rett Syndrome Through DNA Microarray Comparative Genomic HybridizationCompletedNCT02885090
28Study of Cardiac and Paroxysmal Abnormalities in Rett SyndromeCompletedNCT00004773
29Nutritional Aspects of Rett SyndromeCompletedNCT00004656
30Study of the Pathogenesis of Rett SyndromeCompletedNCT00004807
31Advanced Grandparental Age as a Risk Factor for AutismCompletedNCT00464477
32Predictors of Caregiver Adaptation to Pervasive Developmental DisordersCompletedNCT00496210
33The Findings of MR Imaging in Rett SyndromeRecruitingNCT02903056
34Natural History of Rett Syndrome & Related DisordersRecruitingNCT02738281
35Biobanking of Rett Syndrome and Related DisordersRecruitingNCT02705677
36Effects of Standing on Non-Ambulatory Children With Neuromuscular ConditionsRecruitingNCT02428673
37Brainstem and PrematurityRecruitingNCT02669056
38Screening for Studies on Autism Spectrum DisordersRecruitingNCT00271622
39Osteoporosis in RETT SyndromeActive, not recruitingNCT02110797
40Analysis of the Glutathione Cycle in Children With Rett SyndromeWithdrawnNCT02360436

Search NIH Clinical Center for Rett Syndrome


Cochrane evidence based reviews: rett syndrome

Genetic Tests for Rett Syndrome

About this section

Genetic tests related to Rett Syndrome:

id Genetic test Affiliating Genes
1 Rett Syndrome25 23
2 Atypical Rett Syndrome25
3 Rett Syndrome, Zappella Variant25

Anatomical Context for Rett Syndrome

About this section

MalaCards organs/tissues related to Rett Syndrome:

34
Brain, Bone, Testes, Eye, Lung, Skeletal muscle, Cerebellum

Animal Models for Rett Syndrome or affiliated genes

About this section

MGI Mouse Phenotypes related to Rett Syndrome:

39
idDescriptionMGI Source AccessionScoreTop Affiliating Genes
1MP:000539410.3BDNF, CDKL5, DLX5, FOXG1, SYN1
2MP:000538210.1BDNF, DLX5, DLX6, FOXG1, MBD4, MECP2
3MP:00053779.9BDNF, DLX5, DLX6, FOXG1, GPM6B, MECP2
4MP:00053918.9BDNF, CDKL5, CHAT, FOXG1, GPM6B, JMJD1C
5MP:00053868.7BDNF, CDKL5, CHAT, DLX5, FOXG1, GABRA3
6MP:00107688.7BDNF, CHAT, DLX5, DLX6, FOXG1, GPM6B
7MP:00036318.4BDNF, CDKL5, CHAT, DLX5, DLX6, FOXG1

Publications for Rett Syndrome

About this section

Articles related to Rett Syndrome:

(show top 50)    (show all 814)
idTitleAuthorsYear
1
Prevalence and onset of comorbidities in the CDKL5 disorder differ from Rett syndrome. (27080038)
2016
2
Chronic Administration of the N-Methyl-D-Aspartate Receptor Antagonist Ketamine Improves Rett Syndrome Phenotype. (26410354)
2015
3
Rett syndrome and the urge of novel approaches to study MeCP2 functions and mechanisms of action. (24594195)
2014
4
Detection of rarely identified multiple mutations in MECP2 gene do not contribute to enhanced severity in Rett syndrome. (23696494)
2013
5
Respiratory and sleep disorders in female children with atypical Rett syndrome caused by mutations in the CDKL5 gene. (23151060)
2013
6
Investigation of Rett syndrome using pluripotent stem cells. (23744605)
2013
7
Rett syndrome: an eye-tracking study of attention and recognition memory. (23488948)
2013
8
Early socio-communicative forms and functions in typical Rett syndrome. (23891731)
2013
9
Polysomnographic findings in Rett syndrome: a case-control study. (22392651)
2013
10
Location of MECP2 mutation could affect Rett syndrome progression and severity: wider role seen for key gene and protein. (23844427)
2013
11
MeCP2-mediated alterations of striatal features accompany psychomotor deficits in a mouse model of Rett syndrome. (24218106)
2013
12
Recent Progress in Rett Syndrome and MeCP2 Dysfunction: Assessment of Potential Treatment Options. (24348096)
2013
13
Early development and regression in Rett syndrome. (23347273)
2013
14
Cholesterol key in Rett syndrome. (23965551)
2013
15
Novel mutations in the C-terminal region of the MECP2 gene in Tunisian Rett syndrome patients. (21940684)
2012
16
Epileptic seizures, movement disorders, and breathing disturbances in Rett syndrome: diagnostic relevance of video-polygraphy. (23103540)
2012
17
Social impairments in Rett syndrome: characteristics and relationship with clinical severity. (21385260)
2012
18
Linking epigenetics to human disease and Rett syndrome: the emerging novel and challenging concepts in MeCP2 research. (22474603)
2012
19
IGF1 as a Potential Treatment for Rett Syndrome: Safety Assessment in Six Rett Patients. (22934177)
2012
20
Neurodevelopmental disorders: Transplantation therapy in a mouse model of Rett syndrome. (22487748)
2012
21
Preclinical research in Rett syndrome: setting the foundation for translational success. (23115203)
2012
22
The management of gastric perforation in a girl with Rett syndrome: report of a case. (20149564)
2011
23
Rett syndrome: exploring the autism link. (21825235)
2011
24
Altered attainment of developmental milestones influences the age of diagnosis of rett syndrome. (21543746)
2011
25
Methodological note: video analysis of the early development of Rett syndrome--one method for many disciplines. (22136120)
2011
26
Rett syndrome: the state of clinical and basic research, and future perspectives. (21232889)
2011
27
'Relabelling the preserved speech variant of Rett syndrome?'. (20002131)
2010
28
Disrupted microRNA expression caused by Mecp2 loss in a mouse model of Rett syndrome. (20716963)
2010
29
Longevity in Rett syndrome: analysis of the North American Database. (19772971)
2010
30
Suppression of nonsense mutations in Rett syndrome by aminoglycoside antibiotics. (19190538)
2009
31
Correlation between MECP2 genotype and phenotype in Chinese patients with Rett syndrome]. (19573459)
2009
32
A novel CDKL5 mutation in a 47,XXY boy with the early-onset seizure variant of Rett syndrome. (19161156)
2009
33
X chromosome inactivation in Rett Syndrome and its correlations with MECP2 mutations and phenotype. (18184939)
2008
34
Movement disorders in Rett syndrome: an analysis of 60 patients with detected MECP2 mutation and correlation with mutation type. (18512755)
2008
35
Bone ultrasonography at phalanxes in patients with Rett syndrome: a 3-year longitudinal study. (18242156)
2008
36
Environmental enrichment ameliorates a motor coordination deficit in a mouse model of Rett syndrome--Mecp2 gene dosage effects and BDNF expression. (18557922)
2008
37
Will my Rett syndrome patient walk, talk, and use her hands? (18413585)
2008
38
The Israeli Rett Syndrome Center. Evaluation and transdisciplinary play-based assessment. (17041719)
2006
39
Molecular diagnosis of Rett syndrome. (16225827)
2005
40
Mutations found within exon 1 of MECP2 in Danish patients with Rett syndrome. (15857422)
2005
41
Rett syndrome: the complex nature of a monogenic disease. (12750821)
2003
42
DNA methylation and Rett syndrome. (12928486)
2003
43
Rett syndrome. Current status and new vistas. (12616684)
2002
44
A detailed analysis of the MECP2 gene: prevalence of recurrent mutations and gross DNA rearrangements in Rett syndrome patients. (11214906)
2001
45
Gene expression profiling in postmortem Rett Syndrome brain: differential gene expression and patient classification. (11592853)
2001
46
Progressive cardiac dysautonomia observed in patients affected by classic Rett syndrome and not in the preserved speech variant. (11392524)
2001
47
Diagnostic testing for Rett syndrome by DHPLC and direct sequencing analysis of the MECP2 gene: identification of several novel mutations and polymorphisms. (11055898)
2000
48
Effects of Rett syndrome mutations of the methyl-CpG binding domain of the transcriptional repressor MeCP2 on selectivity for association with methylated DNA. (10852707)
2000
49
Two affected boys in a Rett syndrome family: clinical and molecular findings. (11071498)
2000
50
Bromocriptine in the Rett syndrome. (2360701)
1990

Variations for Rett Syndrome

About this section

UniProtKB/Swiss-Prot genetic disease variations for Rett Syndrome:

68 (show all 39)
id Symbol AA change Variation ID SNP ID
1MECP2p.Arg106TrpVAR_010272rs28934907
2MECP2p.Arg133CysVAR_010273rs28934904
3MECP2p.Phe155SerVAR_010274rs28934905
4MECP2p.Thr158MetVAR_010275rs28934906
5MECP2p.Pro101ArgVAR_010276
6MECP2p.Leu124PheVAR_010277
7MECP2p.Ser134CysVAR_010278
8MECP2p.Pro152ArgVAR_010280
9MECP2p.Arg306CysVAR_010282rs28935468
10MECP2p.Leu100ValVAR_017462rs28935168
11MECP2p.Glu10GlnVAR_018180
12MECP2p.Asp97TyrVAR_018182
13MECP2p.Pro101HisVAR_018183
14MECP2p.Pro101LeuVAR_018184
15MECP2p.Pro101ThrVAR_018185
16MECP2p.Arg106GlnVAR_018186
17MECP2p.Arg111GlyVAR_018187
18MECP2p.Gln128ProVAR_018188
19MECP2p.Arg133HisVAR_018189
20MECP2p.Lys135GluVAR_018190
21MECP2p.Asp156GlyVAR_018191
22MECP2p.Lys210IleVAR_018197
23MECP2p.Pro225ArgVAR_018198
24MECP2p.Pro302AlaVAR_018206
25MECP2p.Pro302HisVAR_018207
26MECP2p.Pro302LeuVAR_018208
27MECP2p.Pro302ArgVAR_018209
28MECP2p.Lys305ArgVAR_018210
29MECP2p.Arg306HisVAR_018211
30MECP2p.Pro322AlaVAR_018212
31MECP2p.Pro322LeuVAR_018213
32MECP2p.Arg344TrpVAR_018214
33MECP2p.Asp97GluVAR_023552
34MECP2p.Leu100ArgVAR_023553
35MECP2p.Pro101SerVAR_023554
36MECP2p.Tyr120AspVAR_023555
37MECP2p.Phe155IleVAR_023556
38MECP2p.Thr158AlaVAR_023557
39MECP2p.Gly161ValVAR_023558

Clinvar genetic disease variations for Rett Syndrome:

5 (show all 432)
id Gene Variation Type Significance SNP ID Assembly Location
1CDKL5NM_003159.2(CDKL5): c.455G> T (p.Cys152Phe)single nucleotide variantPathogenicrs122460157GRCh37Chr X, 18600062: 18600062
2CDKL5NM_003159.2(CDKL5): c.525A> T (p.Arg175Ser)single nucleotide variantPathogenicrs61749700GRCh37Chr X, 18602444: 18602444
3CDKL5NM_003159.2(CDKL5): c.2500C> T (p.Gln834Ter)single nucleotide variantPathogenicrs122460158GRCh37Chr X, 18646494: 18646494
4CDKL5NM_003159.2(CDKL5): c.119C> T (p.Ala40Val)single nucleotide variantPathogenicrs122460159GRCh37Chr X, 18582616: 18582616
5CDKL5NM_003159.2(CDKL5): c.215T> C (p.Ile72Thr)single nucleotide variantLikely pathogenic, Pathogenicrs62641235GRCh37Chr X, 18593543: 18593543
6MECP2NM_004992.3(MECP2): c.397C> T (p.Arg133Cys)single nucleotide variantPathogenicrs28934904GRCh37Chr X, 153296882: 153296882
7MECP2NM_004992.3(MECP2): c.464T> C (p.Phe155Ser)single nucleotide variantPathogenicrs28934905GRCh37Chr X, 153296815: 153296815
8MECP2NM_004992.3(MECP2): c.473C> T (p.Thr158Met)single nucleotide variantPathogenicrs28934906GRCh37Chr X, 153296806: 153296806
9MECP2MECP2, 1-BP DEL, 806GdeletionPathogenic
10MECP2MECP2, 44-BP DEL, NT1152deletionPathogenic
11MECP2NM_004992.3(MECP2): c.316C> T (p.Arg106Trp)single nucleotide variantPathogenicrs28934907GRCh37Chr X, 153297719: 153297719
12MECP2NM_004992.3(MECP2): c.808C> T (p.Arg270Ter)single nucleotide variantPathogenicrs61750240GRCh37Chr X, 153296471: 153296471
13MECP2MECP2, IVS2, A-G, -2single nucleotide variantPathogenic
14MECP2NM_004992.3(MECP2): c.1180G> T (p.Glu394Ter)single nucleotide variantPathogenicrs63094662GRCh37Chr X, 153296099: 153296099
15MECP2NM_004992.3(MECP2): c.167_168delCC (p.Pro56Argfs)deletionPathogenicrs267608434GRCh37Chr X, 153297867: 153297868
16MECP2NM_001110792.1(MECP2): c.916C> T (p.Arg306Ter)single nucleotide variantLikely pathogenic, Pathogenic, risk factorrs61751362GRCh37Chr X, 153296399: 153296399
17MECP2MECP2, 41-BP DEL, NT1157deletionPathogenic, risk factor
18MECP2MECP2, 41-BP DEL, NT1159deletionPathogenic
19MECP2NM_004992.3(MECP2): c.419C> T (p.Ala140Val)single nucleotide variantLikely pathogenic, Pathogenicrs28934908GRCh37Chr X, 153296860: 153296860
20MECP2NM_004992.3(MECP2): c.916C> T (p.Arg306Cys)single nucleotide variantPathogenicrs28935468GRCh37Chr X, 153296363: 153296363
21MECP2MECP2, 1-BP DEL, 76CdeletionPathogenic
22MECP2MECP2, 14-BP DUP, NT766duplicationPathogenic
23MECP2NM_004992.3(MECP2): c.502C> T (p.Arg168Ter)single nucleotide variantPathogenicrs61748421GRCh37Chr X, 153296777: 153296777
24MECP2NM_004992.3(MECP2): c.763C> T (p.Arg255Ter)single nucleotide variantPathogenicrs61749721GRCh37Chr X, 153296516: 153296516
25MECP2MECP2, 52-BP DELdeletionPathogenic
26MECP2NM_004992.3(MECP2): c.423C> G (p.Tyr141Ter)single nucleotide variantPathogenicrs61748396GRCh37Chr X, 153296856: 153296856
27MECP2NM_004992.3(MECP2): c.1363G> T (p.Glu455Ter)single nucleotide variantPathogenicrs104894864GRCh37Chr X, 153295916: 153295916
28MECP2NM_004992.3(MECP2): c.298C> G (p.Leu100Val)single nucleotide variantPathogenicrs28935168GRCh37Chr X, 153297737: 153297737
29MECP2MECP2, 11-BP DEL, EX1deletionPathogenic
30MECP2MECP2, 5-BP DUP, EX1duplicationPathogenic
31MECP2MECP2, 1-BP DEL AND 2-BP INSindelPathogenic
32MECP2MECP2, 2-BP DEL, 488GGdeletionPathogenic
33MECP2NM_004992.3(MECP2): c.674C> T (p.Pro225Leu)single nucleotide variantPathogenicrs61749715GRCh37Chr X, 153296605: 153296605
34MECP2NM_001110792.1(MECP2): c.5C> T (p.Ala2Val)single nucleotide variantLikely pathogenic, Pathogenicrs179363901GRCh37Chr X, 153363118: 153363118
35MECP2NM_004992.3(MECP2): c.710delG (p.Gly237Valfs)deletionPathogenicrs61749743GRCh37Chr X, 153296569: 153296569
36MECP2NM_004992.3(MECP2): c.602C> T (p.Ala201Val)single nucleotide variantPathogenicrs61748381GRCh37Chr X, 153296677: 153296677
37MECP2NM_004992.3(MECP2): c.(?_-1)_(26_?)deldeletionPathogenic
38MECP2NM_004992.3(MECP2): c.1009_1027del19 (p.Lys337Glyfs)deletionPathogenicrs267608559GRCh37Chr X, 153296252: 153296270
39MECP2NM_004992.3(MECP2): c.100_103delGATA (p.Asp34Argfs)deletionPathogenicrs61754428GRCh38Chr X, 154032481: 154032484
40MECP2NM_004992.3(MECP2): c.1038C> G (p.Ser346Arg)single nucleotide variantPathogenicrs61752365GRCh37Chr X, 153296241: 153296241
41MECP2NM_004992.3(MECP2): c.1069_1071delAGC (p.Ser357del)deletionPathogenicrs267608564GRCh37Chr X, 153296208: 153296210
42MECP2NM_004992.3(MECP2): c.1079C> A (p.Ser360Ter)single nucleotide variantPathogenicrs61752372GRCh37Chr X, 153296200: 153296200
43MECP2NM_004992.3(MECP2): c.107_108delAA (p.Lys36Argfs)deletionPathogenicrs267608425GRCh37Chr X, 153297927: 153297928
44MECP2NM_001110792.1(MECP2): c.143_149delAAGAAGA (p.Lys48Argfs)deletionPathogenicrs267608424GRCh37Chr X, 153297922: 153297928
45MECP2NM_004992.3(MECP2): c.1087A> T (p.Lys363Ter)single nucleotide variantPathogenicrs61752375GRCh37Chr X, 153296192: 153296192
46MECP2NM_004992.3(MECP2): c.108_111delAGAA (p.Glu37Argfs)deletionPathogenicrs267608426GRCh37Chr X, 153297924: 153297927
47MECP2NM_004992.3(MECP2): c.1099_1118del20 (p.His367Argfs)deletionPathogenicrs267608567GRCh37Chr X, 153296161: 153296180
48MECP2NM_004992.3(MECP2): c.1118C> G (p.Ser373Ter)single nucleotide variantPathogenicrs267608569GRCh37Chr X, 153296161: 153296161
49MECP2NM_001110792.1(MECP2): c.1163_1173delCAAAGGCCCCC (p.Pro388Argfs)deletionPathogenicrs267608570GRCh37Chr X, 153296142: 153296152
50MECP2NM_004992.3(MECP2): c.1145_1194del50 (p.Leu382Profs)deletionPathogenicrs267608573GRCh37Chr X, 153296085: 153296134
51MECP2NM_004992.3(MECP2): c.1150_1192del43 (p.Pro384Thrfs)deletionPathogenicrs63749023GRCh37Chr X, 153296087: 153296129
52MECP2NM_004992.3(MECP2): c.1151_1188del38 (p.Pro384Argfs)deletionPathogenicrs267608574GRCh37Chr X, 153296091: 153296128
53MECP2NM_004992.3(MECP2): c.1151_1191del41 (p.Pro384Argfs)deletionPathogenicrs63749024GRCh37Chr X, 153296088: 153296128
54MECP2NM_001110792.1(MECP2): c.1188_1191delACCC (p.Pro397Cysfs)deletionPathogenicrs267608576GRCh38Chr X, 154030673: 154030676
55MECP2NM_004992.3(MECP2): c.1152_1195del44 (p.Pro385Hisfs)deletionPathogenicrs267608372GRCh37Chr X, 153296084: 153296127
56MECP2NM_004992.3(MECP2): c.1153_1190del38 (p.Pro385Glyfs)deletionPathogenicrs267608577GRCh37Chr X, 153296089: 153296126
57MECP2NM_004992.3(MECP2): c.1154_1185del32 (p.Pro385Leufs)deletionPathogenicrs267608578GRCh37Chr X, 153296094: 153296125
58MECP2NM_004992.3(MECP2): c.1154_1197del44 (p.Pro385Hisfs)deletionPathogenicrs267608579GRCh37Chr X, 153296082: 153296125
59MECP2NM_004992.3(MECP2): c.1155_1183del29 (p.Pro387Argfs)deletionPathogenicrs267608580GRCh37Chr X, 153296096: 153296124
60MECP2NM_004992.3(MECP2): c.1155_1200del46 (p.Leu386Alafs)deletionPathogenicrs267608329GRCh37Chr X, 153296079: 153296124
61MECP2NM_004992.3(MECP2): c.1156_1157dupCT (p.Pro387Cysfs)duplicationPathogenicrs267608584GRCh37Chr X, 153296122: 153296123
62MECP2NM_004992.3(MECP2): c.1156_1172del17 (p.Leu386Terfs)deletionPathogenicrs267608582GRCh37Chr X, 153296107: 153296123
63MECP2NM_004992.3(MECP2): c.1157_1187del31 (p.Leu386Profs)deletionPathogenicrs61754419GRCh37Chr X, 153296092: 153296122
64MECP2NM_004992.3(MECP2): c.1157_1188del32 (p.Leu386Argfs)deletionPathogenicrs267608585GRCh37Chr X, 153296091: 153296122
65MECP2NM_004992.3(MECP2): c.1157_1197del41 (p.Leu386Hisfs)deletionPathogenicrs267608327GRCh37Chr X, 153296082: 153296122
66MECP2NM_004992.3(MECP2): c.1157_1199del43 (p.Leu386Profs)deletionPathogenicrs267608587GRCh37Chr X, 153296080: 153296122
67MECP2NM_004992.3(MECP2): c.1157_1200del44 (p.Leu386Glnfs)deletionPathogenicrs63749748GRCh37Chr X, 153296079: 153296122
68MECP2NM_001110792.1(MECP2): c.1194_1203delGCCCCCACCT (p.Pro399Hisfs)deletionPathogenicrs63583161GRCh37Chr X, 153296112: 153296121
69MECP2NM_004992.3(MECP2): c.1158_1186del29 (p.Pro387Argfs)deletionPathogenicrs63749029GRCh37Chr X, 153296093: 153296121
70MECP2NM_004992.3(MECP2): c.1158_1186del29insCCA (p.Pro387Hisfs)indelPathogenicrs386134271GRCh37Chr X, 153296093: 153296121
71MECP2NM_004992.3(MECP2): c.1158_1198del41 (p.Pro387Glnfs)deletionPathogenicrs267608588GRCh37Chr X, 153296081: 153296121
72MECP2NM_004992.3(MECP2): c.1158_1200del43 (p.Pro387Alafs)deletionPathogenicrs63009262GRCh37Chr X, 153296079: 153296121
73MECP2NM_004992.3(MECP2): c.1159_1160delCCinsT (p.Pro387Serfs)indelPathogenicrs267608590GRCh37Chr X, 153296119: 153296120
74MECP2NM_004992.3(MECP2): c.1159_1201del43 (p.Pro387Alafs)deletionPathogenicrs63749030GRCh37Chr X, 153296078: 153296120
75MECP2NM_001110792.1(MECP2): c.1196_1202delCCCCACC (p.Pro399Leufs)deletionPathogenicrs267608595GRCh37Chr X, 153296113: 153296119
76MECP2NM_004992.3(MECP2): c.1160_1185del26 (p.Pro387Leufs)deletionPathogenicrs267608591GRCh37Chr X, 153296094: 153296119
77MECP2NM_004992.3(MECP2): c.1160_1188del29 (p.Pro387Argfs)deletionPathogenicrs267608593GRCh37Chr X, 153296091: 153296119
78MECP2NM_004992.3(MECP2): c.1160_1200del41 (p.Pro387Glnfs)deletionPathogenicrs267608592GRCh37Chr X, 153296079: 153296119
79MECP2NM_004992.3(MECP2): c.1161_1205del45insA (p.Pro389Terfs)indelPathogenicrs267608596GRCh37Chr X, 153296074: 153296118
80MECP2NM_004992.3(MECP2): c.1163_1179del17 (p.Pro388Argfs)deletionPathogenicrs267608601GRCh37Chr X, 153296100: 153296116
81MECP2NM_004992.3(MECP2): c.1163_1188del26 (p.Pro388Argfs)deletionPathogenicrs267608600GRCh37Chr X, 153296091: 153296116
82MECP2NM_004992.3(MECP2): c.1163_1197del35 (p.Pro388Hisfs)deletionPathogenicrs267608589GRCh37Chr X, 153296082: 153296116
83MECP2NM_004992.3(MECP2): c.1164_1206del43 (p.Pro389Leufs)deletionPathogenicrs267608603GRCh37Chr X, 153296073: 153296115
84MECP2NM_004992.3(MECP2): c.1164_1207del44 (p.Pro389Terfs)deletionPathogenicrs61752992GRCh37Chr X, 153296072: 153296115
85MECP2NM_004992.3(MECP2): c.1164delA (p.Pro389Leufs)deletionPathogenicrs267608606GRCh37Chr X, 153296115: 153296115
86MECP2NM_004992.3(MECP2): c.1165_1190del26 (p.Pro389Glyfs)deletionPathogenicrs267608607GRCh37Chr X, 153296089: 153296114
87MECP2NM_004992.3(MECP2): c.1167_1200del34 (p.Pro390Alafs)deletionPathogenicrs267608343GRCh37Chr X, 153296079: 153296112
88MECP2NM_004992.3(MECP2): c.(?_1169)_(1170_?)del (p.(?))deletionPathogenic
89MECP2NM_004992.3(MECP2): c.1170_1207del38 (p.Pro391Terfs)deletionPathogenicrs267608609GRCh37Chr X, 153296072: 153296109
90MECP2NM_004992.3(MECP2): c.117dupA (p.Glu40Argfs)duplicationPathogenicrs267608427GRCh37Chr X, 153297918: 153297918
91MECP2NM_004992.3(MECP2): c.1189G> T (p.Glu397Ter)single nucleotide variantPathogenicrs56268439GRCh37Chr X, 153296090: 153296090
92MECP2NM_004992.3(MECP2): c.1190dupA (p.Asp398Glyfs)duplicationPathogenicrs267608610GRCh37Chr X, 153296089: 153296089
93MECP2NM_004992.3(MECP2): c.1194_1195insT (p.Pro399Serfs)insertionPathogenicrs61753011GRCh37Chr X, 153296084: 153296085
94MECP2NM_004992.3(MECP2): c.1197dupC (p.Thr400Hisfs)duplicationPathogenicrs267608612GRCh37Chr X, 153296082: 153296082
95MECP2NM_004992.3(MECP2): c.119_120delAG (p.Glu40Glyfs)deletionPathogenicrs267608428GRCh37Chr X, 153297915: 153297916
96MECP2NM_004992.3(MECP2): c.1200dupC (p.Ser401Glnfs)duplicationPathogenicrs267608613GRCh37Chr X, 153296079: 153296079
97MECP2NM_004992.3(MECP2): c.1202dupG (p.Ser401Argfs)duplicationPathogenicrs267608614GRCh37Chr X, 153296077: 153296077
98MECP2NM_004992.3(MECP2): c.1216C> T (p.Gln406Ter)single nucleotide variantPathogenicrs61753965GRCh37Chr X, 153296063: 153296063
99MECP2NM_004992.3(MECP2): c.1223_1265del43 (p.Leu408Serfs)deletionPathogenicrs63749038GRCh37Chr X, 153296014: 153296056
100MECP2NM_004992.3(MECP2): c.1235_1260del26 (p.Val412Glyfs)deletionPathogenicrs267608617GRCh37Chr X, 153296019: 153296044
101MECP2NM_004992.3(MECP2): c.1265_1289del25insAGCGGCCG (p.Gly422Glufs)indelPathogenicrs63749064GRCh37Chr X, 153295990: 153296014
102MECP2NM_004992.3(MECP2): c.126dupG (p.His43Alafs)duplicationPathogenicrs61754430GRCh37Chr X, 153297909: 153297909
103MECP2NM_004992.3(MECP2): c.1308_1309delTC (p.Gln437Alafs)deletionPathogenicrs61753972GRCh37Chr X, 153295970: 153295971
104MECP2NM_004992.3(MECP2): c.1320dupT (p.Ala441Cysfs)duplicationPathogenicrs267608624GRCh37Chr X, 153295959: 153295959
105MECP2NM_004992.3(MECP2): c.1357C> T (p.Arg453Ter)single nucleotide variantPathogenicrs61753979GRCh37Chr X, 153295922: 153295922
106MECP2NM_004992.3(MECP2): c.1364_1365insC (p.Glu455Aspfs)insertionPathogenicrs267608627GRCh37Chr X, 153295914: 153295915
107MECP2NM_004992.3(MECP2): c.(?_1367)_(1431_?)del (p.(?))deletionPathogenic
108MECP2NM_004992.3(MECP2): c.140dupA (p.Pro48Alafs)duplicationPathogenicrs61754431GRCh37Chr X, 153297895: 153297895
109MECP2NM_004992.3(MECP2): c.1450_*12del24deletionPathogenicrs267608637GRCh37Chr X, 153295806: 153295829
110MECP2NM_004992.3(MECP2): c.1450_1453delAGAG (p.Arg484Leufs)deletionPathogenicrs267608638GRCh37Chr X, 153295826: 153295829
111MECP2NM_001110792.1(MECP2): c.1488_1489dupAG (p.Val497Glufs)duplicationPathogenicrs267608639GRCh37Chr X, 153295826: 153295827
112MECP2NM_001110792.1(MECP2): c.1490_1493delTTAG (p.Val497Alafs)deletionLikely pathogenicrs267608640GRCh37Chr X, 153295822: 153295825
113MECP2NM_004992.3(MECP2): c.1455_1456dupTA (p.Ser486Ilefs)duplicationPathogenicrs267608641GRCh37Chr X, 153295823: 153295824
114MECP2NM_004992.3(MECP2): c.146C> A (p.Ser49Ter)single nucleotide variantPathogenicrs61754432GRCh37Chr X, 153297889: 153297889
115MECP2NM_004992.3(MECP2): c.146C> G (p.Ser49Ter)single nucleotide variantPathogenicrs61754432GRCh37Chr X, 153297889: 153297889
116MECP2NM_004992.3(MECP2): c.189_190delGA (p.Glu63Aspfs)deletionPathogenicrs61754436GRCh37Chr X, 153297845: 153297846
117MECP2NM_004992.3(MECP2): c.194C> G (p.Ser65Ter)single nucleotide variantPathogenicrs61754437GRCh37Chr X, 153297841: 153297841
118MECP2NM_004992.3(MECP2): c.201delG (p.Ser68Glnfs)deletionPathogenicrs61754438GRCh37Chr X, 153297834: 153297834
119MECP2NM_004992.3(MECP2): c.203C> G (p.Ser68Ter)single nucleotide variantPathogenicrs267608438GRCh37Chr X, 153297832: 153297832
120MECP2NM_004992.3(MECP2): c.215_216insT (p.Ala73Glyfs)insertionPathogenicrs61754441GRCh37Chr X, 153297819: 153297820
121MECP2NM_004992.3(MECP2): c.215dupC (p.Ala73Glyfs)duplicationPathogenicrs61754441GRCh37Chr X, 153297820: 153297820
122MECP2NM_004992.3(MECP2): c.224C> T (p.Pro75Leu)single nucleotide variantPathogenicrs267608440GRCh37Chr X, 153297811: 153297811
123MECP2NM_004992.3(MECP2): c.233delC (p.Ser78Leufs)deletionPathogenicrs267608442GRCh37Chr X, 153297802: 153297802
124MECP2NM_004992.3(MECP2): c.243dupC (p.Lys82Glnfs)duplicationPathogenicrs267608443GRCh37Chr X, 153297792: 153297792
125MECP2NM_004992.3(MECP2): c.258_259delCA (p.Ile87Hisfs)deletionPathogenicrs267608444GRCh37Chr X, 153297776: 153297777
126MECP2NM_004992.3(MECP2): c.274G> T (p.Gly92Ter)single nucleotide variantPathogenicrs267608445GRCh37Chr X, 153297761: 153297761
127MECP2NM_004992.3(MECP2): c.275dupG (p.Pro93Thrfs)duplicationPathogenicrs267608446GRCh37Chr X, 153297760: 153297760
128MECP2NM_004992.3(MECP2): c.28G> T (p.Glu10Ter)single nucleotide variantPathogenicrs61754421GRCh37Chr X, 153298007: 153298007
129MECP2NM_004992.3(MECP2): c.295_297delACC (p.Thr99del)deletionPathogenicrs267608449GRCh37Chr X, 153297738: 153297740
130MECP2NM_004992.3(MECP2): c.302C> A (p.Pro101His)single nucleotide variantPathogenicrs61754453GRCh37Chr X, 153297733: 153297733
131MECP2NM_004992.3(MECP2): c.302C> G (p.Pro101Arg)single nucleotide variantPathogenicrs61754453GRCh37Chr X, 153297733: 153297733
132MECP2NM_004992.3(MECP2): c.302C> T (p.Pro101Leu)single nucleotide variantPathogenicrs61754453GRCh37Chr X, 153297733: 153297733
133MECP2NM_004992.3(MECP2): c.311G> A (p.Trp104Ter)single nucleotide variantPathogenicrs61754455GRCh37Chr X, 153297724: 153297724
134MECP2NM_001110792.1(MECP2): c.347_359delGGACACGGAAGCT (p.Trp116Leufs)deletionPathogenicrs63749010GRCh37Chr X, 153297712: 153297724
135MECP2NM_004992.3(MECP2): c.315dupA (p.Arg106Thrfs)duplicationPathogenicrs61754456GRCh37Chr X, 153297720: 153297720
136MECP2NM_004992.3(MECP2): c.317G> A (p.Arg106Gln)single nucleotide variantPathogenicrs61754457GRCh37Chr X, 153297718: 153297718
137MECP2NM_004992.3(MECP2): c.326dupA (p.Gln110Alafs)duplicationPathogenicrs267608452GRCh37Chr X, 153297709: 153297709
138MECP2NM_004992.3(MECP2): c.345delC (p.Ser116Leufs)deletionPathogenicrs61755761GRCh37Chr X, 153297690: 153297690
139MECP2NM_001110792.1(MECP2): c.71_78dupAGTCAGAA (p.Asp27Serfs)duplicationPathogenicrs63749008GRCh37Chr X, 153297993: 153298000
140MECP2NM_004992.3(MECP2): c.375delC (p.Asn126Ilefs)deletionPathogenicrs267608457GRCh37Chr X, 153297660: 153297660
141MECP2NM_004992.3(MECP2): c.382C> T (p.Gln128Ter)single nucleotide variantPathogenicrs267608469GRCh37Chr X, 153296897: 153296897
142MECP2NM_004992.3(MECP2): c.398G> A (p.Arg133His)single nucleotide variantPathogenicrs61748389GRCh37Chr X, 153296881: 153296881
143MECP2NM_004992.3(MECP2): c.401C> G (p.Ser134Cys)single nucleotide variantPathogenicrs61748390GRCh37Chr X, 153296878: 153296878
144MECP2NM_004992.3(MECP2): c.411delG (p.Glu137Aspfs)deletionPathogenicrs61748393GRCh37Chr X, 153296868: 153296868
145MECP2NM_004992.3(MECP2): c.413T> A (p.Leu138Ter)single nucleotide variantPathogenicrs267608475GRCh37Chr X, 153296866: 153296866
146MECP2NM_004992.3(MECP2): c.420delG (p.Tyr141Thrfs)deletionPathogenicrs267608476GRCh37Chr X, 153296859: 153296859
147MECP2NM_004992.3(MECP2): c.428_429insT (p.Glu143Aspfs)insertionPathogenicrs61748398GRCh37Chr X, 153296850: 153296851
148MECP2NM_004992.3(MECP2): c.430A> T (p.Lys144Ter)single nucleotide variantPathogenicrs61748399GRCh37Chr X, 153296849: 153296849
149MECP2NM_004992.3(MECP2): c.431delA (p.Lys144Argfs)deletionPathogenicrs61748400GRCh37Chr X, 153296848: 153296848
150MECP2NM_004992.3(MECP2): c.439delG (p.Asp147Thrfs)deletionPathogenicrs62952161GRCh37Chr X, 153296840: 153296840
151MECP2NM_004992.3(MECP2): c.451delG (p.Asp151Thrfs)deletionPathogenicrs61748402GRCh37Chr X, 153296828: 153296828
152MECP2NM_004992.3(MECP2): c.455C> G (p.Pro152Arg)single nucleotide variantPathogenicrs61748404GRCh37Chr X, 153296824: 153296824
153MECP2NM_004992.3(MECP2): c.470_471delTC (p.Phe157Tyrfs)deletionPathogenicrs267608483GRCh38Chr X, 154031357: 154031358
154MECP2NM_004992.3(MECP2): c.470dupT (p.Thr158Hisfs)duplicationPathogenicrs267608482GRCh37Chr X, 153296809: 153296809
155MECP2NM_004992.3(MECP2): c.475delG (p.Val159Terfs)deletionPathogenicrs267608485GRCh37Chr X, 153296804: 153296804
156MECP2NM_004992.3(MECP2): c.480_481delTG (p.Gly161Glufs)deletionPathogenicrs267608486GRCh37Chr X, 153296798: 153296799
157MECP2NM_004992.3(MECP2): c.480delT (p.Arg162Glufs)deletionPathogenicrs61748415GRCh37Chr X, 153296799: 153296799
158MECP2NM_004992.3(MECP2): c.483delG (p.Arg162Glufs)deletionPathogenicrs61748418GRCh37Chr X, 153296796: 153296796
159MECP2NM_004992.3(MECP2): c.484dupA (p.Arg162Lysfs)duplicationPathogenicrs267608487GRCh37Chr X, 153296795: 153296795
160MECP2NM_004992.3(MECP2): c.488_489delGG (p.Gly163Glufs)deletionPathogenicrs267608488GRCh37Chr X, 153296790: 153296791
161MECP2NM_004992.3(MECP2): c.499C> T (p.Arg167Trp)single nucleotide variantPathogenicrs61748420GRCh37Chr X, 153296780: 153296780
162MECP2NM_004992.3(MECP2): c.508C> T (p.Gln170Ter)single nucleotide variantPathogenicrs61748425GRCh37Chr X, 153296771: 153296771
163MECP2NM_004992.3(MECP2): c.50dupA (p.Asp17Glufs)duplicationPathogenicrs267608416GRCh37Chr X, 153297985: 153297985
164MECP2NM_004992.3(MECP2): c.518C> G (p.Pro173Arg)single nucleotide variantPathogenicrs267608492GRCh37Chr X, 153296761: 153296761
165MECP2NM_004992.3(MECP2): c.531delA (p.Lys177Asnfs)deletionPathogenicrs61749703GRCh37Chr X, 153296748: 153296748
166MECP2NM_004992.3(MECP2): c.538A> T (p.Lys180Ter)single nucleotide variantPathogenicrs267608495GRCh37Chr X, 153296741: 153296741
167MECP2NM_004992.3(MECP2): c.543_544delTC (p.Pro182Argfs)deletionPathogenicrs267608496GRCh37Chr X, 153296735: 153296736
168MECP2NM_004992.3(MECP2): c.554delG (p.Gly185Alafs)deletionPathogenicrs61749707GRCh37Chr X, 153296725: 153296725
169MECP2NM_004992.3(MECP2): c.55C> T (p.Gln19Ter)single nucleotide variantPathogenicrs61754425GRCh37Chr X, 153297980: 153297980
170MECP2NM_004992.3(MECP2): c.566delG (p.Gly189Aspfs)deletionPathogenicrs61749708GRCh37Chr X, 153296713: 153296713
171MECP2NM_004992.3(MECP2): c.566dupG (p.Arg190Thrfs)duplicationPathogenicrs267608499GRCh37Chr X, 153296713: 153296713
172MECP2NM_004992.3(MECP2): c.567dupA (p.Arg190Thrfs)duplicationPathogenicrs61749709GRCh37Chr X, 153296712: 153296712
173MECP2NM_004992.3(MECP2): c.56dupA (p.Leu21Profs)duplicationPathogenicrs267608417GRCh37Chr X, 153297979: 153297979
174MECP2NM_004992.3(MECP2): c.592A> T (p.Arg198Ter)single nucleotide variantPathogenicrs61749717GRCh37Chr X, 153296687: 153296687
175MECP2NM_004992.3(MECP2): c.598A> T (p.Lys200Ter)single nucleotide variantPathogenicrs61749718GRCh37Chr X, 153296681: 153296681
176MECP2NM_004992.3(MECP2): c.601dupG (p.Ala201Glyfs)duplicationPathogenicrs267608503GRCh37Chr X, 153296678: 153296678
177MECP2NM_004992.3(MECP2): c.608_609insA (p.Ser204Valfs)insertionPathogenicrs267608506GRCh37Chr X, 153296670: 153296671
178MECP2NM_001110792.1(MECP2): c.647_648delCAinsAG (p.Ser216Ter)indelPathogenicrs267608507GRCh37Chr X, 153296667: 153296668
179MECP2NM_004992.3(MECP2): c.613G> T (p.Glu205Ter)single nucleotide variantPathogenicrs61749726GRCh37Chr X, 153296666: 153296666
180MECP2NM_004992.3(MECP2): c.617delG (p.Gly206Valfs)deletionPathogenicrs61749727GRCh37Chr X, 153296662: 153296662
181MECP2NM_004992.3(MECP2): c.620dupT (p.Gln208Alafs)duplicationPathogenicrs61749728GRCh37Chr X, 153296659: 153296659
182MECP2NM_004992.3(MECP2): c.622C> T (p.Gln208Ter)single nucleotide variantPathogenicrs61749729GRCh37Chr X, 153296657: 153296657
183MECP2NM_004992.3(MECP2): c.(?_631)_(657_?)del (p.(?))deletionPathogenic
184MECP2NM_001110792.1(MECP2): c.677_689delAGAAAAGTCCTGG (p.Glu226Glyfs)deletionLikely pathogenicrs267608386GRCh37Chr X, 153296626: 153296638
185MECP2NM_004992.3(MECP2): c.64A> T (p.Lys22Ter)single nucleotide variantPathogenicrs62641234GRCh37Chr X, 153297971: 153297971
186MECP2NM_004992.3(MECP2): c.651_652delTG (p.Gly218Glufs)deletionPathogenicrs267608510GRCh37Chr X, 153296627: 153296628
187MECP2NM_004992.3(MECP2): c.654_657delGAAG (p.Lys219Serfs)deletionPathogenicrs61749734GRCh37Chr X, 153296622: 153296625
188MECP2NM_004992.3(MECP2): c.673C> A (p.Pro225Thr)single nucleotide variantPathogenicrs267608513GRCh37Chr X, 153296606: 153296606
189MECP2NM_004992.3(MECP2): c.674C> G (p.Pro225Arg)single nucleotide variantPathogenicrs61749715GRCh37Chr X, 153296605: 153296605
190MECP2NM_004992.3(MECP2): c.676_677insA (p.Phe226Tyrfs)insertionPathogenicrs267608514GRCh37Chr X, 153296602: 153296603
191MECP2NM_004992.3(MECP2): c.677_678insA (p.Phe226Leufs)insertionPathogenicrs61749736GRCh37Chr X, 153296601: 153296602
192MECP2NM_004992.3(MECP2): c.686C> A (p.Ser229Ter)single nucleotide variantPathogenicrs61749739GRCh37Chr X, 153296593: 153296593
193MECP2NM_004992.3(MECP2): c.695delG (p.Gly232Alafs)deletionPathogenicrs63260260GRCh37Chr X, 153296584: 153296584
194MECP2NM_004992.3(MECP2): c.695dupG (p.Lys233Glnfs)duplicationPathogenicrs267608516GRCh37Chr X, 153296584: 153296584
195MECP2NM_004992.3(MECP2): c.696delC (p.Lys233Argfs)deletionPathogenicrs61749741GRCh37Chr X, 153296583: 153296583
196MECP2NM_004992.3(MECP2): c.710dupG (p.Gly238Trpfs)duplicationPathogenicrs267608517GRCh37Chr X, 153296569: 153296569
197MECP2NM_004992.3(MECP2): c.720dupC (p.Thr241Hisfs)duplicationPathogenicrs267608518GRCh37Chr X, 153296559: 153296559
198MECP2NM_004992.3(MECP2): c.734_759del26 (p.Val245Glufs)deletionPathogenicrs267608519GRCh37Chr X, 153296520: 153296545
199MECP2NM_004992.3(MECP2): c.736_737insAT (p.Met246Asnfs)insertionPathogenicrs61749749GRCh37Chr X, 153296542: 153296543
200MECP2NM_001110792.1(MECP2): c.772_779delATGGTGATinsGTG (p.Met258Valfs)indelPathogenicrs267608520GRCh37Chr X, 153296536: 153296543
201MECP2NM_004992.3(MECP2): c.739delG (p.Val247Terfs)deletionPathogenicrs61749750GRCh37Chr X, 153296540: 153296540
202MECP2NM_001110792.1(MECP2): c.783_787dupACGCC (p.Pro263Hisfs)duplicationPathogenicrs61749751GRCh37Chr X, 153296528: 153296532
203MECP2NM_004992.3(MECP2): c.748_749insT (p.Arg250Leufs)insertionPathogenicrs61749752GRCh37Chr X, 153296530: 153296531
204MECP2NM_001110792.1(MECP2): c.784_789delCGCCCCinsGGCCG (p.Arg262Glyfs)indelPathogenicrs61750225GRCh37Chr X, 153296526: 153296531
205MECP2NM_004992.3(MECP2): c.748dupC (p.Arg250Profs)duplicationPathogenicrs61749752GRCh37Chr X, 153296531: 153296531
206MECP2NM_001110792.1(MECP2): c.786delCinsTCAGGAAGCTT (p.Pro263Glnfs)indelPathogenicrs267608521GRCh37Chr X, 153296529: 153296529
207MECP2NM_004992.3(MECP2): c.752_753dupCC (p.Gly252Profs)duplicationPathogenicrs267608522GRCh37Chr X, 153296526: 153296527
208MECP2NM_004992.3(MECP2): c.753delC (p.Gly252Alafs)deletionPathogenicrs61750231GRCh37Chr X, 153296526: 153296526
209MECP2NM_004992.3(MECP2): c.753dupC (p.Gly252Argfs)duplicationPathogenicrs61749751GRCh37Chr X, 153296526: 153296526
210MECP2NM_004992.3(MECP2): c.755delG (p.Gly252Alafs)deletionPathogenicrs61750233GRCh37Chr X, 153296524: 153296524
211MECP2NM_004992.3(MECP2): c.755dupG (p.Arg253Glnfs)duplicationPathogenicrs61750232GRCh37Chr X, 153296524: 153296524
212MECP2NM_004992.3(MECP2): c.756_759delCAGG (p.Arg253Serfs)deletionPathogenicrs267608523GRCh37Chr X, 153296520: 153296523
213MECP2NM_001110792.1(MECP2): c.792_799dupCAGGAAGC (p.Arg267Profs)duplicationPathogenicrs61750235GRCh37Chr X, 153296516: 153296523
214MECP2NM_001110792.1(MECP2): c.802_815dupAAAGCTGAGGCCGA (p.Asp272Glufs)duplicationPathogenicrs267608524GRCh37Chr X, 153296500: 153296513
215MECP2NM_004992.3(MECP2): c.76delC (p.Leu26Serfs)deletionPathogenicrs61754426GRCh37Chr X, 153297959: 153297959
216MECP2NM_004992.3(MECP2): c.784C> T (p.Gln262Ter)single nucleotide variantPathogenicrs267608525GRCh37Chr X, 153296495: 153296495
217MECP2NM_004992.3(MECP2): c.792_793delTC (p.Pro265Glnfs)deletionPathogenicrs267608526GRCh37Chr X, 153296486: 153296487
218MECP2NM_004992.3(MECP2): c.799A> T (p.Lys267Ter)single nucleotide variantPathogenicrs61750238GRCh37Chr X, 153296480: 153296480
219MECP2NM_004992.3(MECP2): c.808delC (p.Arg270Glufs)deletionPathogenicrs62931162GRCh37Chr X, 153296471: 153296471
220MECP2NM_004992.3(MECP2): c.810_813delAAAG (p.Lys271Argfs)deletionPathogenicrs267608529GRCh37Chr X, 153296466: 153296469
221MECP2NM_001110792.1(MECP2): c.848_854delAGCCGGG (p.Lys283Argfs)deletionPathogenicrs61750242GRCh37Chr X, 153296461: 153296467
222MECP2NM_004992.3(MECP2): c.816_832del17 (p.Gly273Argfs)deletionPathogenicrs63749012GRCh37Chr X, 153296447: 153296463
223MECP2NM_004992.3(MECP2): c.830delC (p.Ala277Glufs)deletionPathogenicrs61750247GRCh37Chr X, 153296449: 153296449
224MECP2NM_004992.3(MECP2): c.856_859delAAAG (p.Lys286Profs)deletionPathogenicrs61750256GRCh37Chr X, 153296420: 153296423
225MECP2NM_004992.3(MECP2): c.865A> T (p.Lys289Ter)single nucleotide variantPathogenicrs61750259GRCh37Chr X, 153296414: 153296414
226MECP2NM_004992.3(MECP2): c.865_866delAA (p.Lys289Glyfs)deletionPathogenicrs267608536GRCh37Chr X, 153296413: 153296414
227MECP2NM_004992.3(MECP2): c.869dupA (p.Ser291Valfs)duplicationPathogenicrs267608538GRCh37Chr X, 153296410: 153296410
228MECP2NM_004992.3(MECP2): c.874_875insA (p.Ser292Tyrfs)insertionPathogenicrs61751361GRCh37Chr X, 153296404: 153296405
229MECP2NM_001110792.1(MECP2): c.916_920delCGATC (p.Arg306Cysfs)deletionPathogenicrs61751364GRCh37Chr X, 153296395: 153296399
230MECP2NM_004992.3(MECP2): c.881_902del22 (p.Arg294Profs)deletionPathogenicrs267608540GRCh37Chr X, 153296377: 153296398
231MECP2NM_004992.3(MECP2): c.883delT (p.Ser295Leufs)deletionPathogenicrs267608541GRCh37Chr X, 153296396: 153296396
232MECP2NM_004992.3(MECP2): c.889C> T (p.Gln297Ter)single nucleotide variantPathogenicrs61751367GRCh37Chr X, 153296390: 153296390
233MECP2NM_001110792.1(MECP2): c.934_937delGTAC (p.Val312Serfs)deletionPathogenicrs62701461GRCh37Chr X, 153296378: 153296381
234MECP2NM_001110792.1(MECP2): c.934_940delGTACTCC (p.Val312Profs)deletionPathogenicrs267608543GRCh37Chr X, 153296375: 153296381
235MECP2NM_004992.3(MECP2): c.898delG (p.Val300Tyrfs)deletionPathogenicrs267608544GRCh37Chr X, 153296381: 153296381
236MECP2NM_004992.3(MECP2): c.905C> G (p.Pro302Arg)single nucleotide variantPathogenicrs61749723GRCh37Chr X, 153296374: 153296374
237MECP2NM_004992.3(MECP2): c.906delC (p.Ile303Serfs)deletionPathogenicrs267608548GRCh37Chr X, 153296373: 153296373
238MECP2NM_004992.3(MECP2): c.917G> A (p.Arg306His)single nucleotide variantPathogenicrs61751443GRCh37Chr X, 153296362: 153296362
239MECP2NM_004992.3(MECP2): c.91delG (p.Val31Terfs)deletionPathogenicrs61754427GRCh37Chr X, 153297944: 153297944
240MECP2NM_004992.3(MECP2): c.925C> T (p.Arg309Trp)single nucleotide variantPathogenicrs61751444GRCh37Chr X, 153296354: 153296354
241MECP2NM_004992.3(MECP2): c.964C> G (p.Pro322Ala)single nucleotide variantPathogenicrs61751449GRCh37Chr X, 153296315: 153296315
242MECP2NM_001110792.1(MECP2)indelPathogenicrs672601302GRCh37Chr X, 153296285: 153296290
243MECP2NM_004992.3(MECP2): c.994_998delAGCGG (p.Ser332Glufs)deletionPathogenicrs267608558GRCh37Chr X, 153296281: 153296285
244CDKL5NM_003159.2(CDKL5): c.1311dupC (p.Ser438Glnfs)duplicationPathogenicrs267608623GRCh37Chr X, 18622355: 18622355
245CDKL5NM_003159.2(CDKL5): c.163_166delGAAA (p.Glu55Argfs)deletionPathogenicrs267608433GRCh37Chr X, 18593491: 18593494
246CDKL5NM_003159.2(CDKL5): c.1648C> T (p.Arg550Ter)single nucleotide variantPathogenicrs267608643GRCh37Chr X, 18622692: 18622692
247CDKL5NM_003159.2(CDKL5): c.1675C> T (p.Arg559Ter)single nucleotide variantPathogenicrs267608395GRCh37Chr X, 18622719: 18622719
248CDKL5NM_003159.2(CDKL5): c.1708G> T (p.Glu570Ter)single nucleotide variantPathogenicrs267608644GRCh37Chr X, 18622752: 18622752
249CDKL5NM_003159.2(CDKL5): c.175C> T (p.Arg59Ter)single nucleotide variantPathogenicrs62653623GRCh37Chr X, 18593503: 18593503
250CDKL5NM_003159.2(CDKL5): c.183delT (p.Met63Cysfs)deletionPathogenicrs62643608GRCh37Chr X, 18593511: 18593511
251CDKL5NM_003159.2(CDKL5): c.1892_1893dupTA (p.Gly632Terfs)duplicationPathogenicrs267608646GRCh37Chr X, 18622936: 18622937
252CDKL5NM_003159.2(CDKL5): c.2045_2046delAGins18 (p.?)indelPathogenicrs672601303GRCh37Chr X, 18627031: 18627032
253CDKL5NM_003159.2(CDKL5): c.215T> A (p.Ile72Asn)single nucleotide variantPathogenicrs62641235GRCh37Chr X, 18593543: 18593543
254CDKL5NM_003159.2(CDKL5): c.2343delG (p.Arg781Serfs)deletionPathogenicrs62643614GRCh37Chr X, 18638053: 18638053
255CDKL5NM_003159.2(CDKL5): c.2635_2636delCT (p.Leu879Glufs)deletionPathogenicrs61753251GRCh37Chr X, 18646629: 18646630
256CDKL5NM_003159.2(CDKL5): c.352C> T (p.Gln118Ter)single nucleotide variantPathogenicrs267608453GRCh37Chr X, 18598037: 18598037
257CDKL5NM_003159.2(CDKL5): c.380A> G (p.His127Arg)single nucleotide variantLikely pathogenic, Pathogenicrs267608468GRCh37Chr X, 18598065: 18598065
258CDKL5NM_003159.2(CDKL5): c.532C> T (p.Arg178Trp)single nucleotide variantLikely pathogenic, Pathogenicrs267608493GRCh37Chr X, 18602451: 18602451
259CDKL5NM_003159.2(CDKL5): c.607G> T (p.Glu203Ter)single nucleotide variantPathogenicrs267608505GRCh37Chr X, 18606126: 18606126
260CDKL5NM_003159.2(CDKL5): c.838_847delTTGGACCCAG (p.Asp281Thrfs)deletionPathogenicrs61750250GRCh37Chr X, 18616594: 18616603
261MECP2NM_004992.3(MECP2): c.26+2T> Asingle nucleotide variantPathogenicrs267608409GRCh38Chr X, 154092182: 154092182
262MECP2NM_004992.3(MECP2): c.27-2A> Gsingle nucleotide variantPathogenicrs267608412GRCh38Chr X, 154032559: 154032559
263MECP2NM_004992.3(MECP2): c.27-6C> Gsingle nucleotide variantPathogenicrs267608411GRCh38Chr X, 154032563: 154032563
264MECP2NM_004992.3(MECP2): c.377+1G> Asingle nucleotide variantPathogenicrs267608463GRCh37Chr X, 153297657: 153297657
265MECP2NM_004992.3(MECP2): c.377+1G> Tsingle nucleotide variantPathogenicrs267608463GRCh38Chr X, 154032206: 154032206
266MECP2NM_004992.3(MECP2): c.378-2A> Csingle nucleotide variantPathogenicrs267608464GRCh38Chr X, 154031452: 154031452
267MECP2NM_004992.3(MECP2): c.378-2A> Gsingle nucleotide variantPathogenicrs267608464GRCh38Chr X, 154031452: 154031452
268MECP2NM_004992.3(MECP2): c.378-2A> Tsingle nucleotide variantPathogenicrs267608464GRCh37Chr X, 153296903: 153296903
269MECP2NM_004992.3(MECP2): c.378-3C> Gsingle nucleotide variantPathogenicrs267608465GRCh37Chr X, 153296904: 153296904
270CDKL5NM_003159.2(CDKL5): c.145+2T> Csingle nucleotide variantPathogenicrs267608430GRCh37Chr X, 18582644: 18582644
271CDKL5NM_003159.2(CDKL5): c.2047-1G> Asingle nucleotide variantPathogenicrs267608650GRCh38Chr X, 18609464: 18609464
272CDKL5NM_003159.2(CDKL5): c.463+1G> Asingle nucleotide variantPathogenicrs267608479GRCh37Chr X, 18600071: 18600071
273MECP2NM_004992.3(MECP2): c.1116_1201del86 (p.His372Glnfs)deletionPathogenicGRCh38Chr X, 154030627: 154030712
274CDKL5NM_003159.2(CDKL5): c.211A> G (p.Asn71Asp)single nucleotide variantLikely pathogenic, Pathogenicrs587783072GRCh38Chr X, 18575419: 18575419
275MECP2NM_001110792.1(MECP2): c.1A> T (p.Met1Leu)single nucleotide variantPathogenicrs587783132GRCh38Chr X, 154097665: 154097665
276MECP2NM_001110792.1(MECP2): c.520A> G (p.Arg174Gly)single nucleotide variantPathogenicrs727505391GRCh37Chr X, 153296795: 153296795
277MECP2NM_004992.3(MECP2): c.573delC (p.Ser194Alafs)deletionLikely pathogenicrs786204307GRCh37Chr X, 153296706: 153296706
278MECP2NM_001110792.1(MECP2): c.738_752delTGAGGGGGGTGGGGC (p.Glu247_Ala251del)deletionLikely pathogenicrs786204309GRCh38Chr X, 154031112: 154031126
279MECP2NM_001110792.1(MECP2): c.790_818del29 (p.Gly264Serfs)deletionLikely pathogenicrs786204310GRCh38Chr X, 154031046: 154031074
280MECP2NM_001110792.1(MECP2): c.853_871dup19 (p.Ala291Glyfs)duplicationLikely pathogenicrs786204311GRCh38Chr X, 154030993: 154031011
281MECP2NM_001110792.1(MECP2): c.1289_1492del204 (p.Met430_Val497del)deletionPathogenicGRCh38Chr X, 154030372: 154030575
282MECP2NM_004992.3(MECP2): c.1410_1411delCA (p.Asn470Lysfs)deletionLikely pathogenicrs786204316GRCh37Chr X, 153295868: 153295869
283MECP2NM_001110792.1(MECP2): c.863_*44del679deletionLikely pathogenicGRCh38Chr X, 154030323: 154031001
284CDKL5NM_003159.2(CDKL5): c.1090G> T (p.Glu364Ter)single nucleotide variantPathogenicrs786204966GRCh38Chr X, 18604014: 18604014
285CDKL5NM_003159.2(CDKL5): c.1341delC (p.Phe447Leufs)deletionPathogenicrs786204968GRCh37Chr X, 18622385: 18622385
286CDKL5NM_003159.2(CDKL5): c.1375C> T (p.Gln459Ter)single nucleotide variantPathogenicrs786204969GRCh37Chr X, 18622419: 18622419
287CDKL5NM_003159.2(CDKL5): c.1417dupA (p.Ile473Asnfs)duplicationPathogenicrs786204970GRCh38Chr X, 18604341: 18604341
288CDKL5NM_003159.2(CDKL5): c.1550delT (p.Phe517Serfs)deletionPathogenicrs786204972GRCh37Chr X, 18622594: 18622594
289CDKL5NM_003159.2(CDKL5): c.-162-?_99+?deldeletionPathogenic
290CDKL5NM_003159.2(CDKL5): c.1854delC (p.Asp618Glufs)deletionPathogenicrs786204975GRCh37Chr X, 18622898: 18622898
291CDKL5NM_003159.2(CDKL5): c.2046+1G> Asingle nucleotide variantPathogenicrs786204976GRCh38Chr X, 18608913: 18608913
292CDKL5NM_003159.2(CDKL5): c.(?_-253)_-162-27968deldeletionPathogenicGRCh37Chr X, 18443725: 18497087
293CDKL5NM_003159.2(CDKL5): c.-253_64+?deldeletionPathogenicGRCh38Chr X, 18425605: 18507160
294CDKL5NM_003159.2(CDKL5): c.-253_99+?deldeletionPathogenicGRCh38Chr X, 18425605: 18510854
295CDKL5NM_003159.2(CDKL5): c.2704C> T (p.Gln902Ter)single nucleotide variantPathogenicrs786204981GRCh38Chr X, 18628578: 18628578
296CDKL5NM_003159.2(CDKL5): c.283-3_290del11deletionPathogenicrs786204983GRCh37Chr X, 18597965: 18597975
297CDKL5NM_003159.2(CDKL5): c.403+1G> Asingle nucleotide variantPathogenicrs786204984GRCh38Chr X, 18579969: 18579969
298CDKL5NM_003159.2(CDKL5): c.404-?_554+?deldeletionPathogenic
299CDKL5NM_003159.2(CDKL5): c.464-1G> Asingle nucleotide variantPathogenicrs786204986GRCh37Chr X, 18602382: 18602382
300CDKL5NM_003159.2(CDKL5): c.510_511dupGT (p.Tyr171Cysfs)duplicationPathogenicrs786204988GRCh38Chr X, 18584309: 18584310
301CDKL5NM_003159.2(CDKL5): c.528G> T (p.Trp176Cys)single nucleotide variantPathogenicrs786204989GRCh38Chr X, 18584327: 18584327
302CDKL5NM_003159.2(CDKL5): c.660_664dupTTTTA (p.Thr222Ilefs)duplicationPathogenicrs786204990GRCh37Chr X, 18606179: 18606183
303CDKL5NM_003159.2(CDKL5): c.942delA (p.Lys314Asnfs)deletionPathogenicrs786204992GRCh38Chr X, 18598578: 18598578
304MECP2NM_004992.3(MECP2): c.(?_1169)_*(1_?)deldeletionPathogenicGRCh38Chr X, 154030366: 154030659
305MECP2NM_004992.3(MECP2): c.1012_1193del182 (p.Thr338Profs)deletionPathogenicGRCh38Chr X, 154030635: 154030816
306MECP2NM_004992.3(MECP2): c.1012_1202del191 (p.Thr338Profs)deletionPathogenicGRCh37Chr X, 153296077: 153296267
307MECP2NM_004992.3(MECP2): c.(?_1017)_(1397_?)del (p.(?))deletionPathogenicGRCh37Chr X, 153295882: 153296262
308NC_000023.10: g.153281346_153296256del14911deletionPathogenicGRCh37Chr X, 153281346: 153296256
309MECP2NM_001110792.1(MECP2): c.1064_1194del131 (p.Gly355Alafs)deletionPathogenicGRCh38Chr X, 154030670: 154030800
310MECP2NM_004992.3(MECP2): c.1030_1195del166insGT (p.Arg344Valfs)indelPathogenicGRCh38Chr X, 154030633: 154030798
311MECP2NM_004992.3(MECP2): c.1039_1195del157insGT (p.Lys347Valfs)indelPathogenicGRCh38Chr X, 154030633: 154030789
312MECP2NM_004992.3(MECP2): c.(?_1044)_(1442_?)del (p.(?))deletionPathogenicGRCh38Chr X, 154030386: 154030784
313MECP2NM_004992.3(MECP2): c.1046_1206del161 (p.Ser349Thrfs)deletionPathogenicGRCh37Chr X, 153296073: 153296233
314MECP2NM_001110792.1(MECP2): c.1084_1235del152 (p.Ser362Glnfs)deletionPathogenicGRCh38Chr X, 154030629: 154030780
315MECP2NM_004992.3(MECP2): c.1052_1200del149 (p.Pro351Glnfs)deletionPathogenicGRCh37Chr X, 153296079: 153296227
316MECP2NM_004992.3(MECP2): c.1057_1219del163 (p.Gly353Thrfs)deletionPathogenicGRCh37Chr X, 153296060: 153296222
317MECP2NM_004992.3(MECP2): c.1078_*2524del2908deletionPathogenicGRCh38Chr X, 154027843: 154030750
318MECP2NM_004992.3(MECP2): c.1096_1201del106 (p.His366Alafs)deletionPathogenicGRCh37Chr X, 153296078: 153296183
319MECP2NM_004992.3(MECP2): c.1097_*13del378deletionPathogenicGRCh37Chr X, 153295805: 153296182
320MECP2NM_004992.3(MECP2): c.1097_1203del107 (p.His366Profs)deletionPathogenicGRCh38Chr X, 154030625: 154030731
321MECP2NM_004992.3(MECP2): c.1101_1201del101 (p.His367Glnfs)deletionPathogenicGRCh38Chr X, 154030627: 154030727
322MECP2NM_004992.3(MECP2): c.1101_(1396_?)del (p.His(368_?)Alafs)deletionPathogenicGRCh38Chr X, 154030432: 154030727
323MECP2NM_004992.3(MECP2): c.1105_1225del121 (p.His369Alafs)deletionPathogenicGRCh37Chr X, 153296054: 153296174
324MECP2NM_004992.3(MECP2): c.1115_1326del212 (p.His372Argfs)deletionPathogenicGRCh37Chr X, 153295953: 153296164
325MECP2NM_004992.3(MECP2): c.1121_1191del71 (p.Glu374Glyfs)deletionPathogenicGRCh37Chr X, 153296088: 153296158
326MECP2NM_004992.3(MECP2): c.1123_1202del80 (p.Ser375Profs)deletionPathogenicGRCh38Chr X, 154030626: 154030705
327MECP2NM_004992.3(MECP2): c.1127_1179del53 (p.Pro376Argfs)deletionPathogenicGRCh37Chr X, 153296100: 153296152
328MECP2NM_001110792.1(MECP2): c.1165_*568delinsCCGTGGindelPathogenicGRCh37Chr X, 153295250: 153296150
329MECP2NM_004992.3(MECP2): c.1132_1202del71 (p.Ala378Profs)deletionPathogenicGRCh38Chr X, 154030626: 154030696
330MECP2NM_004992.3(MECP2): c.1142_1227del86 (p.Pro381Glnfs)deletionPathogenicGRCh37Chr X, 153296052: 153296137
331MECP2NM_001110792.1(MECP2): c.1188_*29del339deletionPathogenicGRCh38Chr X, 154030338: 154030676
332MECP2NM_004992.3(MECP2): c.1157_*944del1249deletionPathogenicGRCh37Chr X, 153294874: 153296122
333MECP2NM_004992.3(MECP2): c.1159_1458del300 (p.Pro387_Ser486del)deletionPathogenicGRCh38Chr X, 154030370: 154030669
334MECP2NM_004992.3(MECP2): c.1163_*39del338deletionPathogenicGRCh37Chr X, 153295779: 153296116
335MECP2NM_001110792.1(MECP2)indelPathogenicrs786205019GRCh37Chr X, 153296095: 153296115
336MECP2NM_004992.3(MECP2): c.1164_1194del31 (p.Pro391Alafs)deletionPathogenicrs786205020GRCh38Chr X, 154030634: 154030664
337MECP2NM_004992.3(MECP2): c.(?_1169)_(1397_?)del (p.(?))deletionPathogenicGRCh37Chr X, 153295882: 153296110
338MECP2NM_004992.3(MECP2): c.1180_1181insT (p.Glu394Valfs)insertionPathogenicrs786205021GRCh37Chr X, 153296098: 153296099
339MECP2NM_004992.3(MECP2): c.1196_1266del71 (p.Pro399Leufs)deletionPathogenicGRCh38Chr X, 154030562: 154030632
340MECP2NM_004992.3(MECP2): c.1276_*113del299ins3indelPathogenicGRCh37Chr X, 153295705: 153296003
341MECP2NM_004992.3(MECP2): c.(?_1336)_*(1_?)deldeletionPathogenicGRCh38Chr X, 154030366: 154030492
342MECP2NM_001110792.1(MECP2): c.1444_1447delAACAinsTG (p.Asn482Trpfs)indelPathogenicrs786205023GRCh38Chr X, 154030417: 154030420
343MECP2NM_004992.3: c.(?_184)_(1065_?)deldeletionPathogenic
344MECP2NM_004992.3(MECP2): c.(?_-226)_(*1_?)deldeletionPathogenic
345MECP2NM_004992.3(MECP2): c.(?_-226)_26+?deldeletionPathogenicGRCh37Chr X, 153357642: 153363188
346MECP2NM_004992.3(MECP2): c.(?_248)_(320_?)del (p.(?))deletionPathogenicGRCh38Chr X, 154032264: 154032336
347NC_000023.10indelPathogenicGRCh37Chr X, 153281940: 153332471
348MECP2NM_004992.3: c.(?_27)_(378_1461)deldeletionPathogenic
349MECP2NM_004992.3: c.(?_27)_(*1_?)deldeletionPathogenic
350MECP2NM_004992.3: c.(?_27)_(*8554_?)deldeletionPathogenic
351MECP2NM_004992.3: c.(?_27)_(1018_?)deldeletionPathogenic
352MECP2NM_004992.3: c.(?_27)_(1021_?)deldeletionPathogenic
353MECP2NM_004992.3: c.(?_27)_(1029_?)deldeletionPathogenic
354MECP2NM_004992.3: c.(?_27)_(1170_?)deldeletionPathogenic
355MECP2NM_004992.3: c.(?_27)_(1185_?)deldeletionPathogenic
356MECP2NM_004992.3: c.(?_27)_(1337_?)deldeletionPathogenic
357MECP2NM_004992.3: c.(?_27)_(1397_?)deldeletionPathogenic
358MECP2NM_004992.3(MECP2): c.(?_27)_(367_?)del (p.(?))deletionPathogenicGRCh37Chr X, 153297668: 153298008
359MECP2NM_004992.3: c.(?_27)_(378_?)deldeletionPathogenic
360MECP2NM_004992.3(MECP2): c.27-12521_*5072deldeletionPathogenicGRCh38Chr X, 154025295: 154045078
361MECP2NM_004992.3(MECP2): c.27-3928_1184deldeletionPathogenicGRCh38Chr X, 154030644: 154036485
362MECP2NM_004992.3(MECP2): c.27-4722_*112delinsCACTTTGTGindelPathogenicGRCh37Chr X, 153295706: 153302730
363MECP2NM_004992.3(MECP2): c.27-4722_*739delins43indelPathogenicGRCh38Chr X, 154029628: 154037279
364MECP2NM_004992.3(MECP2): c.27-5774_902delinsGTGCCCGGACTGATGTCAindelPathogenicGRCh38Chr X, 154030926: 154038331
365MECP2NM_004992.3(MECP2): c.27-6026_1190delinsGTindelPathogenicGRCh38Chr X, 154030638: 154038583
366MECP2NM_004992.3(MECP2): c.27-6215_1190deldeletionPathogenicGRCh38Chr X, 154030638: 154038772
367MECP2NM_004992.3(MECP2): c.27-96_1205deldeletionPathogenicGRCh38Chr X, 154030623: 154032653
368MECP2NM_001110792.1(MECP2): c.354_357dupGAAG (p.Leu120Glufs)duplicationPathogenicrs786205025GRCh38Chr X, 154032263: 154032266
369MECP2NM_004992.3: c.343_1182deldeletionPathogenic
370MECP2NM_004992.3(MECP2): c.(?_378)_*(1_?)deldeletionPathogenicGRCh37Chr X, 153295817: 153296901
371MECP2NM_004992.3(MECP2): c.(?_378)_(1170_?)del (p.(?))deletionPathogenicGRCh37Chr X, 153296109: 153296901
372MECP2NM_004992.3(MECP2): c.(?_378)_(1185_?)del (p.(?))deletionPathogenicGRCh37Chr X, 153296094: 153296901
373MECP2NM_004992.3(MECP2): c.(?_378)_(1337_?)del (p.(?))deletionPathogenicGRCh37Chr X, 153295942: 153296901
374MECP2NM_001110792.1(MECP2): c.414_1497del1084 (p.Pro139Phefs)deletionPathogenicGRCh37Chr X, 153295818: 153296901
375MECP2NM_004992.3(MECP2): c.382_1189del808 (p.Gln128Argfs)deletionPathogenicGRCh38Chr X, 154030639: 154031446
376MECP2NM_001110792.1(MECP2): c.445_1194del750 (p.Glu149_Leu398del)deletionPathogenicGRCh37Chr X, 153296121: 153296870
377MECP2NM_004992.3(MECP2): c.481_987del507ins8indelPathogenicGRCh38Chr X, 154030841: 154031347
378MECP2NM_004992.3(MECP2): c.488_1189del702 (p.Gly163_Ser396del)deletionPathogenicGRCh38Chr X, 154030639: 154031340
379MECP2NM_004992.3(MECP2): c.502C> A (p.Arg168=)single nucleotide variantPathogenicrs61748421GRCh37Chr X, 153296777: 153296777
380MECP2NM_004992.3(MECP2): c.616_1122del507 (p.Gly206_Glu374del)deletionPathogenicGRCh38Chr X, 154030706: 154031212
381MECP2NM_004992.3(MECP2): c.689_756del68 (p.Pro230Glnfs)deletionPathogenicGRCh38Chr X, 154031072: 154031139
382MECP2NM_004992.3(MECP2): c.711_1269del559 (p.Gly238Trpfs)deletionPathogenicGRCh37Chr X, 153296010: 153296568
383MECP2NM_004992.3(MECP2): c.731_1166del436 (p.Gln244Leufs)deletionPathogenicGRCh37Chr X, 153296113: 153296548
384MECP2NM_004992.3(MECP2): c.763_1383del621ins15 (p.?)indelPathogenicGRCh37Chr X, 153295896: 153296516
385MECP2NM_004992.3(MECP2): c.766A> T (p.Lys256Ter)single nucleotide variantPathogenicrs786205027GRCh37Chr X, 153296513: 153296513
386MECP2NM_004992.3(MECP2): c.767_1175del409 (p.Lys256Serfs)deletionPathogenicGRCh37Chr X, 153296104: 153296512
387MECP2NM_004992.3(MECP2): c.785_818del34 (p.Gln262Argfs)deletionPathogenicrs786205028GRCh37Chr X, 153296461: 153296494
388MECP2NM_004992.3(MECP2): c.820_1153del334ins67 (p.?)indelPathogenicGRCh38Chr X, 154030675: 154031008
389MECP2NM_004992.3(MECP2): c.822_1184del363 (p.Val275_Ser395del)deletionPathogenicGRCh37Chr X, 153296095: 153296457
390MECP2NM_004992.3(MECP2): c.830_831ins23 (p.?)insertionPathogenicrs786205029GRCh37Chr X, 153296448: 153296449
391MECP2NM_004992.3(MECP2): c.834_939del106 (p.Ala279Serfs)deletionPathogenicGRCh37Chr X, 153296340: 153296445
392MECP2NM_004992.3(MECP2): c.849_1236del388 (p.Lys284Alafs)deletionPathogenicGRCh37Chr X, 153296043: 153296430
393MECP2NM_004992.3(MECP2): c.851_1188del338 (p.Lys284Argfs)deletionPathogenicGRCh37Chr X, 153296091: 153296428
394MECP2NM_004992.3(MECP2): c.855_859delGAAAGinsAAAAAAAAGACT (p.Ala287Lysfs)indelPathogenicrs786205030GRCh38Chr X, 154030969: 154030973
395MECP2NM_001110792.1(MECP2): c.903_1259del357insA (p.Ser303Glnfs)indelPathogenicGRCh38Chr X, 154030605: 154030961
396MECP2NM_001110792.1(MECP2): c.905_916delAGTCTTCTATCCinsCACA (p.Glu302Alafs)indelPathogenicrs786205031GRCh38Chr X, 154030948: 154030959
397MECP2NM_001110792.1(MECP2): c.907_1080del174 (p.Ile305_Ser362del)deletionPathogenicGRCh37Chr X, 153296235: 153296408
398MECP2NM_004992.3(MECP2): c.894_1095del202 (p.Glu298Aspfs)deletionPathogenicGRCh37Chr X, 153296184: 153296385
399MECP2NM_004992.3(MECP2): c.898_1099del202 (p.Val300Thrfs)deletionPathogenicGRCh37Chr X, 153296180: 153296381
400MECP2NM_001110792.1(MECP2): c.942_1174del233insAC (p.Ile315_Val392delinsLeu)indelPathogenicGRCh37Chr X, 153296141: 153296373
401MECP2NM_004992.3(MECP2): c.914_1172del259 (p.Lys305Metfs)deletionPathogenicGRCh37Chr X, 153296107: 153296365
402MECP2NM_004992.3(MECP2): c.943_1140del198ins6indelPathogenicGRCh37Chr X, 153296139: 153296336
403MECP2NM_001110792.1(MECP2): c.998_1303del306insG (p.Lys333Serfs)indelPathogenicGRCh37Chr X, 153296012: 153296317
404MECP2NM_004992.3(MECP2): c.-98-?_377+?deldeletionPathogenic
405MECP2NM_004992.3(MECP2): c.994_1346del353 (p.Ser332Valfs)deletionPathogenicGRCh37Chr X, 153295933: 153296285
406MECP2NM_001110792.1(MECP2): c.23_27dupCGCCG (p.Ser10Argfs)duplicationPathogenicrs786205038GRCh38Chr X, 154097639: 154097643
407MECP2NM_001110792.1(MECP2): c.30delCinsGA (p.Ser10Argfs)indelPathogenicrs786205040GRCh38Chr X, 154097636: 154097636
408MECP2NM_001110792.1(MECP2): c.47_57delGCGAGGAGGAG (p.Gly16Glufs)deletionPathogenicrs786205042GRCh38Chr X, 154097609: 154097619
409MECP2NM_001110792.1(MECP2): c.48_55delCGAGGAGG (p.Glu18Thrfs)deletionPathogenicrs786205043GRCh38Chr X, 154097611: 154097618
410MECP2NM_001110792.1(MECP2): c.48_55dupCGAGGAGG (p.Glu19Alafs)duplicationPathogenicrs786205044GRCh38Chr X, 154097611: 154097618
411MECP2NM_001110792.1(MECP2): c.48C> T (p.Gly16=)single nucleotide variantPathogenicrs786205045GRCh38Chr X, 154097618: 154097618
412MECP2NM_001110792.1(MECP2): c.59_60delGA (p.Arg20Thrfs)deletionPathogenicrs786205047GRCh38Chr X, 154097606: 154097607
413MECP2NM_001110792.1(MECP2): c.62+2_62+3delTGdeletionPathogenicrs786205049GRCh37Chr X, 153363058: 153363059
414MECP2NM_001110792.1(MECP2): c.(?_1)_(62_?)del (p.(?))deletionPathogenicGRCh38Chr X, 154097604: 154097665
415MECP2NM_004992.3(MECP2): c.1A> T (p.Met1Leu)single nucleotide variantPathogenicrs786205892GRCh37Chr X, 153357667: 153357667
416MECP2NM_004992.3(MECP2)indelPathogenicGRCh38Chr X, 154030545: 154030665
417MECP2NM_004992.3(MECP2): c.1146_*452del768deletionPathogenicGRCh37Chr X, 153295366: 153296133
418MECP2NM_004992.3(MECP2): c.390delA (p.Ala131Profs)deletionPathogenicrs786205895GRCh37Chr X, 153296889: 153296889
419MECP2NM_001110792.1(MECP2): c.1202dupC (p.Pro402Serfs)duplicationPathogenicrs797044733GRCh37Chr X, 153296113: 153296113
420MECP2NM_001110792.1(MECP2): c.1043_1230del188 (p.Leu348Profs)deletionPathogenicGRCh37Chr X, 153296085: 153296272
421MECP2NM_001110792.1(MECP2): c.1193_*116del421deletionPathogenicGRCh37Chr X, 153295702: 153296122
422MECP2NM_001110792.1(MECP2): c.30_31delCG (p.Ser10Argfs)deletionPathogenicrs797045693GRCh38Chr X, 154097635: 154097636
423MECP2NM_001110792.1(MECP2): c.83_93delAGGACCTCCAG (p.Gln28Argfs)deletionPathogenicrs797045694GRCh37Chr X, 153297978: 153297988
424MECP2NM_001110792.1(MECP2): c.701_707dupTCAAGAT (p.Met236Ilefs)duplicationPathogenicrs797045695GRCh37Chr X, 153296608: 153296614
425MECP2NM_001110792.1(MECP2): c.934_1202del269 (p.Val312Serfs)deletionPathogenicGRCh37Chr X, 153296113: 153296381
426MECP2NM_001110792.1: c.384_1164deldeletionPathogenic
427MECP2NM_004992.3(MECP2): c.650C> T (p.Pro217Leu)single nucleotide variantLikely pathogenicrs878853312GRCh37Chr X, 153296629: 153296629
428MECP2NM_004992.3(MECP2): c.574A> T (p.Lys192Ter)single nucleotide variantLikely pathogenic, Pathogenicrs193922679GRCh37Chr X, 153296705: 153296705
429MECP2NM_004992.3(MECP2): c.468C> G (p.Asp156Glu)single nucleotide variantPathogenicrs61748408GRCh37Chr X, 153296811: 153296811
430MECP2NM_004992.3(MECP2): c.611C> G (p.Ser204Ter)single nucleotide variantPathogenicrs61749724GRCh37Chr X, 153296668: 153296668
431MECP2NM_004992.3(MECP2): c.730C> T (p.Gln244Ter)single nucleotide variantPathogenicrs61749747GRCh37Chr X, 153296549: 153296549
432MECP2NM_004992.3(MECP2): c.806delG (p.Gly269Alafs)deletionPathogenicrs61750241GRCh37Chr X, 153296473: 153296473

Copy number variations for Rett Syndrome from CNVD:

6 (show top 50)    (show all 64)
id CNVD ID Chromosom Start End Type Gene Symbol CNVD Disease
12247211669890617124554Copy numberCROCCRett syndrome
22247311669890617124554Copy numberMSTP9Rett syndrome
32247411669890617124554Duplication or delet ionESPNPRett syndrome
4256211192100000197500000Copy numberCFHR1Rett syndrome
5256221192100000197500000Copy numberCFHR3Rett syndrome
6285921223731557223870819DuplicationENAHRett syndrome
733645146852126246794522Duplication or delet ionOR2T34Rett syndrome
843286104610000050100000Copy numberGPRIN2Rett syndrome
943406104639616346568496Copy numberPPYR1Rett syndrome
1043589104701759847161232DuplicationRett syndrome
118255710105781035105835628Copy numberCOL17A1Rett syndrome
12825586105717459105777332DeletionSLKRett syndrome
1382938141862438319484013Copy numberOR4K1Rett syndrome
1482939141862438319484013Copy numberOR4K2Rett syndrome
1582940141862438319484013Copy numberOR4K5Rett syndrome
1682941141862438319484013Copy numberOR4M1Rett syndrome
1782942141862438319484013Copy numberOR4N2Rett syndrome
1882943141862438319484013Copy numberOR4Q3Rett syndrome
1982944141862438319484013Deletion or duplicat ionOR11H13PRett syndrome
2089640151881000419537035DeletionRett syndrome
2191690153252324132572315DeletionRett syndrome
2299799162873229528952218Copy numberATP2A1Rett syndrome
2399800162873229528952218Copy numberCD19Rett syndrome
2499801162873229528952218Copy numberLATRett syndrome
2599802162873229528952218Copy numberNFAC2IPRett syndrome
2699803162873229528952218Copy numberRABEP2Rett syndrome
2799804162873229528952218Copy numberSH2B1Rett syndrome
2899805162873229528952218Copy numberSPNS1Rett syndrome
2999806162873229528952218Copy numberTUFMRett syndrome
3099807162873229528952218DuplicationATXN2LRett syndrome
31101278163439954334539890DuplicationRett syndrome
32112972174154422441706870DuplicationKIAA1267Rett syndrome
331441802242514593242655973DeletionRett syndrome
34144868230609753460506Copy numberTTC15Rett syndrome
35144869230609753460506DeletionTSSC1Rett syndrome
361495411246822753246823692DeletionOR2T10Rett syndrome
37162851222268199522712211DuplicationGSTT1Rett syndrome
38165049224123773141287060Copy numberSERHL2Rett syndrome
39165050224123773141287060DuplicationSERHLRett syndrome
401669203110116098110397433Copy numberC3orf66Rett syndrome
411669213110116098110397433Copy numberMORC1Rett syndrome
421669223110116098110397433DuplicationGUCA1CRett syndrome
431712083163997228164101776DeletionRett syndrome
441738333196905767196942158DuplicationMUC20Rett syndrome
4518884946905773569165814Duplication or delet ionUGT2B17Rett syndrome
462020385763944848744DuplicationZDHHC11Rett syndrome
472083656168114265168324002Copy numberC6orf54Rett syndrome
482083666168114265168324002Copy numberFRMD1Rett syndrome
492083676168114265168324002Copy numberKIF25Rett syndrome
502083686168114265168324002DuplicationMLLT4Rett syndrome

Expression for genes affiliated with Rett Syndrome

About this section
LifeMap Discovery
Genes differentially expressed in tissues of Rett Syndrome patients vs. healthy controls: 33 (show all 47)
id Gene Description Tissue Up/Dn Fold Change (log2) P value
1EPHB2EPH receptor B2Brain+6.860.000
2SLC9A3R1solute carrier family 9, subfamily A (NHE3, cation proton antiporter 3), member 3 regulator 1Brain+5.980.000
3CARTPTCART prepropeptideBrain-5.940.000
4GLRA2glycine receptor, alpha 2Brain+5.440.000
5APOC4apolipoprotein C-IVBrain-5.140.039
6FLOT2flotillin 2Brain+5.090.017
7GRIN2Cglutamate receptor, ionotropic, N-methyl D-aspartate 2CBrain+5.020.012
8ACVR2Bactivin A receptor, type IIBBrain+4.940.000
9ASMTacetylserotonin O-methyltransferaseBrain+4.780.000
10DCTN5dynactin 5 (p25)Brain+4.720.000
11F2RL1coagulation factor II (thrombin) receptor-like 1Brain-4.690.004
12INHBBinhibin, beta BBrain+4.590.028
13FOLR1folate receptor 1 (adult)Brain-4.590.006
14NPRL3NPR3-like, GATOR1 complex subunitBrain+4.450.044
15CCDC106coiled-coil domain containing 106Brain-4.430.047
16S100A1S100 calcium binding protein A1Brain+4.300.045
17CCScopper chaperone for superoxide dismutaseBrain+4.290.027
18MKL1megakaryoblastic leukemia (translocation) 1Brain+4.190.012
19ASB4ankyrin repeat and SOCS box containing 4Brain+4.150.012
20CHRNB2cholinergic receptor, nicotinic, beta 2 (neuronal)Brain+4.080.049
21SOX11SRY (sex determining region Y)-box 11Brain+3.980.000
22KIFC3kinesin family member C3Brain+3.910.017
23APBA3amyloid beta (A4) precursor protein-binding, family A, member 3Brain-3.870.012
24CCHCR1coiled-coil alpha-helical rod protein 1Brain+3.830.026
25ITGA9integrin, alpha 9Brain+3.820.036
26MYL5myosin, light chain 5, regulatoryBrain+3.740.000
27KCNMA1potassium channel, calcium activated large conductance subfamily M alpha, member 1Brain+3.690.028
28SFTPBsurfactant protein BBrain-3.480.003
29XPNPEP1X-prolyl aminopeptidase (aminopeptidase P) 1, solubleBrain+3.480.044
30HNRNPFheterogeneous nuclear ribonucleoprotein FBrain+3.470.010
31PPP1R3Cprotein phosphatase 1, regulatory subunit 3CBrain+3.450.008
32TBX1T-box 1Brain+3.410.008
33MYCLv-myc avian myelocytomatosis viral oncogene lung carcinoma derived homologBrain+3.390.007
34TRADDTNFRSF1A-associated via death domainBrain+3.360.010
35NFATC1nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 1Brain-3.330.019
36PANX1pannexin 1Brain+3.300.019
37ENOSF1enolase superfamily member 1Brain+3.290.024
38MT4metallothionein 4Brain-3.200.001
39FEZ2fasciculation and elongation protein zeta 2 (zygin II)Brain+3.170.001
40IFNA5interferon, alpha 5Brain+3.160.006
41CEP57centrosomal protein 57kDaBrain+3.130.029
42ZG16zymogen granule protein 16Brain+3.120.045
43ADAM10ADAM metallopeptidase domain 10Brain+3.090.039
44ATP7BATPase, Cu++ transporting, beta polypeptideBrain+3.090.046
45ESR1estrogen receptor 1Brain+3.070.017
46ZKSCAN8zinc finger with KRAB and SCAN domains 8Brain-3.070.006
47EGFRepidermal growth factor receptorBrain+3.030.030

Search GEO for disease gene expression data for Rett Syndrome.

Pathways for genes affiliated with Rett Syndrome

About this section

GO Terms for genes affiliated with Rett Syndrome

About this section

Biological processes related to Rett Syndrome according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1anatomical structure formation involved in morphogenesisGO:004864610.5DLX5, DLX6
2head developmentGO:006032210.5DLX5, DLX6
3response to estradiolGO:003235510.3MBD4, MECP2, TH
4memoryGO:000761310.3CHAT, MECP2, TH
5axonogenesisGO:000740910.0DLX5, NTNG1, NTNG2
6nervous system developmentGO:00073999.6BDNF, DLX5, DLX6, GPM6B

Sources for Rett Syndrome

About this section
2CDC
6CNVD
10DGIdb
15ExPASy
16FDA
17FMA
25GTR
26HGMD
27HMDB
28ICD10
29ICD10 via Orphanet
30ICD9CM
31IUPHAR
32KEGG
35MedGen
37MeSH
38MESH via Orphanet
39MGI
42NCI
43NCIt
44NDF-RT
47NINDS
48Novoseek
50OMIM
51OMIM via Orphanet
55PubMed
56QIAGEN
61SNOMED-CT via Orphanet
65Tumor Gene Family of Databases
66UMLS
67UMLS via Orphanet